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5ABstRACt
The formation of micronuclei (MN) in peripheral blood lymphocytes 
represents one of the earliest cytogenetic effects of exposure to genotoxic 
carcinogens. An increased frequency of MN and of other cytogenetic 
alterations, such as chromosomal aberrations and sister chromatid ex-
changes, in a well controlled study of occupationally exposed people, is 
usually considered a strong indication of exposure to genotoxic carcino-
gens, requiring improvements in protective measures. Such considera-
tions are further suppor ted by epidemiological studies, suggesting that 
a high frequency of chromosomal aberrations and MN is predictive of 
an increased risk of cancer.
This study was performed to obtain comprehensive information 
about the suitability of the lymphocyte micronucleus assay (MN assay) 
in examining the effects of occupational exposure to genotoxic carcino-
gens. MN, defined as small, additional nuclei, are formed in mitosis 
from acentric chromosomal fragments or chromosomes that lag behind 
in anaphase and eventually fail to be included in either of the daughter 
nuclei. The primary objectives of this dissertation were to clarify factors 
affecting the mechanistic origin of MN and to assess the influence of 
some methodological aspects in the MN assay. The differentiation of MN 
harbouring fragments from those containing whole chromosomes was 
considered a main goal, in order to estimate whether these two classes 
of MN should be analyzed separately. Methodologically, the influence 
of cell culture time and the use of the cytokinesis-block method on the 
frequency and contents of MN were assessed, as well as the possibility 
to analyze MN in vivo from uncultured T-lymphocytes. In addition, 
the suitability of bromodeoxyuridine (BrdU) labeling as an alternative 
method to the cytokinesis-block technique was investigated in green-
6ABSTRACT
house workers occupationally exposed to pesticides. Furthermore, some 
genetic polymorphisms (GSTM1, GSTT1 and NAT2) were also studied 
in the greenhouse workers to reveal their possible role as modifiers of 
individual response to the occupational exposure. Finally, mechanis-
tic aspects concerning the formation of MN from chromosomes and 
fragments lagging behind in anaphase, with a special reference to the 
X chromosome, were assessed.
By using pancentromeric fluorescence in situ hybridization (FISH), 
considerable pro portions of MN were found to contain whole chromo-
somes or chromatids. The frequency of this type of MN was both age- 
and culture-time-dependent. Micronucleus analysis using the anti-BrdU 
staining technique showed that the pesticide-exposed greenhouse workers, 
in particular exposed smokers, had a higher micronucleus frequency than 
their respective controls. Subjects with the GSTM1 positive and NAT2 
fast acetylator genotypes had higher frequencies of MN, but this effect 
was not related to the pesticide exposure. Comparison of the proportion 
of various types of MN in cultured and uncultured T-lymphocytes of 
women, using a pancentromeric and a centromeric X-chromosome spe-
cific DNA probe, indicated that in vivo MN in T-lymphocytes primarily 
consist of whole chromosomes, especially the X-chromosome. In general, 
the X chromosome was highly over-represented in female MN, and cell 
culture further increased the frequency of X-chromosome-positive MN. 
The high micronucleation of the X-chromosome appeared to be due to 
its frequent lagging behind in anaphase. Reciprocal chromosome gain 
and loss in lymphocytes was more common for the X-chromosome both 
in men and women than for the Y-chromosome in men. The results of 
this dissertation strongly suggest that, when MN are used as a biomar-
ker of human genotoxic effects, the recognition of the contents of MN 
is of utmost importance and is expected to improve the specificity and 
sensitivity of the assay. Furthermore, the direct analysis of MN in uncul-
tured peripheral T lymphocytes, combined with centromeric FISH, may 
provide a new possibility for the assessment of chromosome breakage 
and numerical chromosome alterations occurring in vivo.
7ABstRACt In FInnIsH  
– tIIVIstELMÄ
Mikrotumien lisääntyminen perifeerisen veren lymfosyyteissä on en-
simmäisiä sytogeneettisiä vaikutuksia altistuttaessa syöpää aiheuttaville 
genotoksisille tekijöille. Työntekijöillä tehdyissä tutkimuksissa mikro- 
tumien ja muiden sytogeneettisten muutosten, kuten kromosomiaber-
raatioiden ja sisarkromatidivaihdosten, määrän kohoamista kontrolliryh-
mään verrattuna pidetään selkeänä osoituksena altistumisesta genotok-
sisille karsinogeeneille ja perusteena korjaaville toimenpiteille. Tätä 
näkemystä tukevat epidemiologiset tutkimukset, jotka ovat osoittaneet, 
että kromosomiaberraatioiden ja mikrotumien määrän lisääntyminen 
ennakoi kohonnutta syöpäriskiä.
Tämän tutkimuksen tarkoituksena oli saada uutta tietoa lymfosyyt-
tien mikrotuma-analyysin käyttökelpoisuudesta tutkittaessa työperäistä 
altistumista genotoksisille karsinogeeneille. Mikrotumat ovat pieniä, 
ylimääräisiä tumia, joita muodostuu, kun kromosomifragmentit tai 
kokonaiset kromosomit jäävät tuman jakautuessa jälkeen muista kromo- 
someista eivätkä kulkeudu tytärtumiin. Tämän väitöskirjan päätavoit-
teena oli selventää mikrotumien syntymekanismeja ja eräiden mene-
telmällisten tekijöiden merkitystä mikrotuma-analyysissä. Keskeinen 
päämäärä oli erottaa fragmentteja sisältävät mikrotumat kokonaisia 
kromosomeja sisältävistä mikrotumista, jotta voitaisiin arvioida, tulisiko 
näitä mikrotumien pääryhmiä tarkastella erikseen. Menetelmällisistä 
kysymyksistä keskityttiin selvittämään, miten lymfosyyttien viljelyaika ja 
sytokineesiblokki-menetelmän käyttö vaikuttavat mikrotumien sisältöön 
ja esiintymistiheyteen ja voidaanko mikrotumia tutkia T-lymfosyyteistä 
ilman soluviljelyä. Lisäksi pestiseideille työperäisesti altistuneilla kasvi-
huonetyöntekijöillä tutkittiin mahdollisuutta käyttää sytokineesiblokki-
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menetelmän sijasta bromodeoksiuridiini (BrdU) -leimausta vaihtoeh-
toisena metodina. Työntekijöiltä tutkittiin myös, vaikuttaako eräiden 
vierasaineenvaihduntaan liittyvien geenien (GSTM1, GSTT1 ja NAT2) 
geneettinen monimuotoisuus henkilökohtaiseen mikrotumavasteeseen 
työperäisessä altistumisessa. Lopuksi selvitettiin, miten mikrotumia 
muodostuu tuman jakautumisen aikana jälkeen jäävistä kokonaisista 
kromosomeista ja kromosomien fragmenteista.
Kun mikrotumien sisältöä tutkittiin fluoresenssi in situ hybridisaa-
tio (FISH) -menetelmällä, valtaosan mikrotumista havaittiin sisältävän 
kokonaisia kromosomeja tai kromatideja. Tämän tyyppisten mikrotu-
mien esiintymistiheys lisääntyi iän ja viljelyajan myötä. Käyttämällä 
antibromodeoksiuridiini-värjäystekniikkaa osoitettiin, että pestisideille 
altistuneilla kasvihuonetyöntekijöillä, erityisesti altistuneilla tupakoit-
sijoilla, oli korkeampi mikrotumafrekvenssi kuin kontrollihenkilöllä. 
GSTM1-positiivinen genotyyppi ja nopean asetylaation NAT2-geno-
tyyppi liittyivät korkeaan mikrotumafrekvenssiin, mutta niillä ei ollut 
yhteisvaikutuksia pestisidialtistumisen kanssa. Kun T-lymfosyyttien mik-
rotumien sisältöä tutkittiin käyttäen pansentromeeristä ja X-kromosomin 
sentromeerin DNA-koetinta ennen soluviljelyä ja sen jälkeen, ilmeni, 
että in vivo -mikrotumat sisältävät pääosin kokonaisia kromosomeja. 
Erityisesti X-kromosomi oli selvästi yliedustettuna tutkittujen naisten 
mikrotumissa, ja solujen viljely lisäsi vielä X-kromosomin sisältävien 
mikrotumien esiintymistiheyttä. X-kromosomin yleisyys mikrotumissa 
näytti selittyvän sillä, että X-kromosomi jää odotettua useammin jäl-
keen muista kromosomeista tuman jakautumisen anafaasi-vaiheessa. 
X-kromosomin virheellinen segregaatio tytärtumien välillä oli odotettua 
yleisempää sekä naisilla että miehillä, ja miehillä virhe koski useammin 
X-kromosomia kuin Y-kromosomia. Väitöskirjan tulos viittaa vahvasti 
siihen, että mikrotumien sisällön tunnistaminen on erityisen tärkeää 
menetelmän spesifisyyden ja herkkyyden kannalta, kun mikrotuma-
analyysiä käytetään genotoksisen vaikutuksen biomarkkerina työn-
tekijätutkimuksissa. T-lymfosyyttien suora analyysi ilman soluviljelyä 
yhdistettynä pansentromeeriseen FISHiin tarjoaa uuden mahdollisuuden 
mitata kromosomikatkoksista ja kokonaisista kromosomeista in vivo 
syntyneiden mikrotumien esiintymistiheyttä.
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IntROdUCtIOn 
Human exposure to chemicals is basically an inevitable part of life in 
this day and age. In general, upon exposure, the chemical agent is often 
absorbed into the receptor bloodstream via three primary routes – 
inhalation into the lungs, oral ingestion, and dermal/skin contact 
(Asante-Duah 2002). Exposure to various chemical and physical agents 
both in the working environment as well as during the free time can dam-
age DNA (deoxyribonucleic acid). Many genotoxic chemicals are known 
to act by binding to DNA, forming covalent complexes (adducts) with 
its constituent DNA nucleotides. Unless repaired, these adducts can lead 
to cell death or mutation by interfering with cell replication and other 
cellular processes (Vuyyuri et al. 2006). Such DNA-damaging genotoxic 
agents are known to have serious biologic effects, most importantly, they 
may eventually cause cancer. Although chemical exposures are in general 
considered to be decreasing in workplaces of the industrial society, there 
are still many examples of notable occupational genotoxic exposures, 
often to complex chemical mixtures containing a high number of differ-
ent genotoxic components. Due to this complexity, exposure assessment 
may be difficult by traditional chemical techniques.
Most human carcinogens are genotoxic but not all genotoxic agents 
have been shown to be carcinogenic in humans. In monitoring of 
genotoxic effects of carcinogens in humans, the discovery of suitable 
biological markers is very important for hazard identification and risk 
assessment. In exposure to genotoxic carcinogens, a biological marker 
(i.e. biomarker) can be described as any event or component that is 
detectable or measurable in the human body and may influence or pre-
dict the incidence or outcome of the genotoxic insult. Using traditional 
criteria, biomarkers can be divided into markers of exposure, effects, and 
14
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susceptibility (Fenech and Morley 1985; Tucker et al. 1997; Salama et al. 
1999). Distinction between these classes, especially between biomarkers 
of exposure and effect, is not always clear. The former serves as a measure 
of exposure and the latter as an indicator of cancer risk. Inter-individual 
biological variability affects biomarkers of both exposure and effect. This 
variability may be assessed using biomarkers of susceptibility which can be 
used to detect subjects who have higher probability of an adverse effect.
Many biomarkers have been developed to estimate exposure and to 
assess the risk of adverse effects in an early phase. Monitoring of biologi-
cal effects as a measure of the internally effective dose may especially be 
relevant for the assessment of the ultimate health risks, namely cancer. 
Structural and numerical chromosomal alterations assessed with tradi-
tional cytogenetic methods, the analyses of chromosomal aberrations 
(CAs), sister chromatid exchanges (SCEs), and micronuclei (MN), are 
among the genotoxicity effect markers most often used (Carrano and 
Natarajan 1988; Albertini et al. 2000; Norppa 2004a). Other widely 
used markers of genotoxicity include covalent binding products (ad-
ducts) to DNA, other types of DNA damage (strand breaks, crosslinks, 
alkali-labile sites), and somatic gene mutations (hypoxanthine-guanine 
phosphoribosyl transferase (HPRT) and glycophorin A genes) (Albertini 
et al. 2000; Lander et al. 2000). The use of these methods is based on the 
fact that most established human carcinogens are genotoxic in short-term 
tests and capable of inducing chromosome damage (Waters et al. 1999). 
The mechanistic basis varies for different genotoxicity endpoints, and for 
some it has not fully been elucidated. Although exposure to a variety of 
different genotoxic carcinogens can be detected using these biomarkers, 
the causative agent cannot always be identified unambiguously, except 
in the case of specific DNA adducts.
In the last decade, it has become clear that genetic pre-disposition 
may affect individual susceptibility to cancer and carcinogen-induced 
biomarkers of exposure and effect. Genetic susceptibility can be due to 
variation in genes coding for carcinogen-metabolizing enzymes, such as 
cytochrome P450 (CYP) and glutathione S-transferases (GST) (Worm-
houdt et al. 1999; Norppa 2004a). In practice, biomarkers of exposure 
(substance or its metabolites in biological fluids, urinary mutagenicity, 
protein and DNA adducts) and of effects (CA, SCE, MN, mutations) 
may be affected by the genotype (and phenotype) of several activating/
15
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detoxifying metabolic activities. Further more, biomarkers of effect may 
be influenced by genetic polymorphisms of DNA repair genes and other 
genes important for genomic integrity.
The present dissertation concentrates on one cytogenetic genotoxic-
ity biomarker, namely MN in peripheral lymphocytes. MN are formed 
from both whole and fragmented chromosomes that lag behind in cell 
division and are eventually left outside the daughter nuclei (see (Norppa 
and Falck 2003). In general, micronucleus analysis is utilized in both ge-
notoxicity testing and biomonitoring of genotoxic exposure and effect in 
humans. MN are particularly considered a useful biomarker of genotoxic 
effects in populations exposed to genotoxicants in occupational settings. 
In principle, the micronucleus assay (MN assay) allows the detection of 
both aneugenic agents (inducing numerical chromosome alterations) 
and clastogenic agents (inducing chromosome breakage) and can be 
applied, in addition to peripheral lymphocytes, to cells exfoliated from 
buccal, nasal and urothelial mucosa (Albertini et al. 2000; Pastor et al. 
2001; Norppa and Falck 2003; Holland et al. 2008). When peripheral 
lymphocytes are examined, the cytokinesis-block method (Fenech and 
Morley 1985) is most often used. In comparison with other cytogenetic 
techniques, the cytokinesis-block micronucleus (CBMN) assay is a rela-
tively rapid and simple test in which cells that have divided once in culture 
are identified by the use of cytochalasin B (Cyt-B) (Fenech 1993). This 
dissertation especially addresses the applicability of the MN assay as a 
biomarker in occupational exposure. Factors affecting the baseline level 
of MN and mechanisms of micronucleus formation are also evaluated, 
and the feasibility of some new methodological approaches is assessed.
16
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REVIEW OF tHE LItERAtURE 
Cytogenetic biomarkers of chromosomal 
damage
Cytogenetic biomarkers such as chromosomal aberrations (CAs), sister 
chromatid exchanges (SCEs), and MN have for many years been used 
for surveillance of human genotoxic exposure and cytogenetically visible 
early effects (Albertini et al. 2000). The use of these biomarkers is based 
on the fact that most established human carcinogens are genotoxic in 
short-term tests and capable of inducing chromosome damage (Waters 
et al. 1999). Furthermore, epidemiological studies have suggested that a 
high frequency of (structural) CAs in lymphocytes (Hagmar et al. 1998; 
Bonassi et al. 2000; Bonassi et al. 2008) and MN in peripheral blood 
lymphocytes (Bonassi et al. 2007) is predictive of an increased cancer 
risk lending support to the relevance of using the cytogenetic methods.
Chromosomal aberrations
Chromosomal aberrations (CAs) can be defined as microscopically 
visible changes in normal chromosome structure in cells. They can be 
formed spontaneously during the cell cycle or after chemical (or radia-
tion-) treatment as a result of misrepaired or unrepaired DNA lesions 
(Russell 2002). CAs are mostly scored in proliferating cells – arrested 
after culturing at the metaphase stage using a tubulin polymerization 
inhibitor (e.g., Colcemid®), fixed, spread on microscope slides, and 
subsequently stained with solid Giemsa-stain (Dean 1984) (see Figure 
1 A). The CA assay is primarily used for the analysis of structural CAs 
which, based on morphological criteria, are classified into two main 
17
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categories, chromosome-type (involving both chromatids of one or 
multiple chromosomes; see Figure 1 A) and chromatid-type aberrations 
(involving only one of the two chromatids of a chromosome or several 
chromosomes) (Albertini et al. 2000; Hagmar et al. 2004). In both 
categories, breaks and various types of rearrangements are distinguished 
(examples of chromosome-type aberrations illustrated in Figure 1 A). 
Structural CAs may be induced by direct DNA damage, by replication 
on a damaged DNA template, by inhibition of DNA synthesis and by 
other mechanisms (e.g. topoisomerase II inhibitors) (Albertini et al. 
2000). In the formation of chromosome-type CAs; double strand DNA 
breaks (DSB) are considered to be the primary lesions (Pfeiffer et al. 
2000). However, the analysis of CAs is not suitable for the evaluation of 
numerical CAs because artefactual chromosome loss may occur during 
slide preparation (Mateuca et al. 2006).
Figure 1. Microscopic images of human lymphocyte metaphases. A. An 
aberrant male metaphase stained with Giemsa. The aberrations consist of 
three dicentric chromosomes (long arrows) and three acentric fragments 
(short arrows). B. A female metaphase stained with the fluorescence-plus-
Giemsa technique, showing eight sister chromatid exchanges. Arrows mark 
the sites of exchange. Photographs kindly provided by Hilkka Järventaus.
18
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In occupational and environmental contexts, the analysis of structural 
CAs in peripheral blood lymphocytes has been used for more than 30 
years as a biomarker of early effects of genotoxic carcinogens (Hagmar 
et al. 2004). The frequency of CAs, determined by ordinary metaphase 
analysis, has in several studies been shown to be associated with a higher 
cancer risk (Hagmar et al. 1994; Bonassi et al. 1995; Hagmar et al. 1998; 
Liou et al. 1999; Bonassi et al. 2000; Smerhovsky et al. 2001; Smerhovsky 
et al. 2002; Rossner et al. 2005; Bonassi et al. 2008). Because of these 
findings, the traditional CA assay is still much used in studies of human 
exposure to chemical genotoxins and ionizing radiation.
Newer techniques for the analysis of translocations and intrachromo-
somal rearrange ments, based on fluorescence in situ hybridization (FISH 
painting), have been applied in radiation studies (Obe et al. 2002).
sister chromatid exchanges
During S-phase of the cell cycle, DNA is replicated so that each chro-
mosome becomes duplicated into two closely associated daughter chro-
matids joined at the centromere. SCEs are formed during the S-phase, 
sister chromatids breaking and rejoining with one another, physically 
exchanging regions. SCEs thus result from symmetrical DNA exchanges 
occurring during replication between the sister chromatids of the same 
chromosome, at homologous loci (Wolff 1975; Wolff et al. 1977; Car-
rano et al. 1979; Wilson and Thompson 2007). The exchange process 
has been suggested to represent homologous recombination repair of 
DNA double-strand breaks (Sonoda et al. 1999; Johnson and Jasin 2000; 
Wilson and Thompson 2007) or of single-strand breaks or other lesions 
converted into double-strand breaks at the replication fork (collapsed 
replication fork) (Helleday 2003). DNA interstrand cross-link has been 
suggested to be a major lesion leading to SCEs (Wojcik et al. 2004). 
Presumably, there may be more than one molecular pathway responsible 
for SCEs (Wilson and Thompson 2007).
In humans, SCEs are scored from second-division metaphases 
of PHA-stimulated lymphocytes after cell culture in the presence of 
5-bromodeoxyuridine (BrdU) which enables differential staining of 
sister chromatids. BrdU is a DNA base analogue which is incorporated 
into the DNA during replication replacing thymine. If cells incorporate 
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BrdU during at least two cell cycles, the second mitotic division contains 
chromosomes where one sister chromatid is bifilarly and the other uni-
filarly substituted with BrdU (see Figure 1 B). Detection of SCEs can 
be achieved after differential staining with a combination of Hoechst 
33258 and Giemsa (Perry and Wolff 1974) (fluorescence-plus-Giemsa 
technique; see Figure 1 B). A new technique for SCE analysis, based on 
the use of biotin-16-2’-deoxyuridine-5’-triphosphate was described by 
Wojcik et al. (2004).
As the number of SCEs is obtained for each cell scored, the assay 
is inherently sensitive and has been popular both in experimental and 
human biomarker studies. Since the biological significance of the SCE 
event is still elusive (Bonassi and Au 2002; Norppa et al. 2006), further 
studies are needed, e.g., to judge whether SCE analysis could be used as 
a marker of homologous recombination. Although SCE frequency is a 
useful parameter in well-controlled investigations of exposure to chemical 
genotoxins, it has not turned out to have cancer risk predictivity (Hagmar 
et al. 1998; Bonassi et al. 2000; Bonassi et al. 2004). One of the reasons 
for this finding is probably technical variation in SCE frequencies which 
makes it difficult to combine SCE data from different studies (Norppa 
et al. 2006). The usage of SCEs has progressively disappeared from the 
scientific literature (Bonassi et al. 2005).
Micronuclei
MN are small, extranuclear bodies additional to the main nucleus in a 
cell. They are formed when whole chromatids, chromosomes and acentric 
fragments are left behind and eventually excluded from the daughter 
nuclei at mitosis (Heddle et al. 1983; Ford et al. 1988; Lindholm et al. 
1991; Ford and Correll 1992). Laggards cannot move towards the poles, 
because they are detached from the mitotic spindle or, alternatively, have 
bipolar (merotelic) kinetochore orientation (e.g. one kinetochore is at-
tached to microtubules from both poles instead of just one), as described 
by Cimini et al. (2001). Besides these fundamental mechanisms, some 
MN may have their origin in fragments derived from broken anaphase 
bridges (Cornforth and Goodwin 1991; Saunders et al. 2000; Huang et 
al. 2011) formed due to chromosome rearrangements (dicentric chro-
matids, concate nated ring chromosomes or union of sister chromatids) 
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(Norppa and Falck 2003). In the microscope, a micronucleus is visual-
ized as an extra small nucleus beside the main nucleus of an interphase 
cell as shown in Figure 2.
The MN assay can be described as a variation of the CA assay. Instead 
of detecting an aberration at the metaphase stage of the cell cycle, MN 
are first detected after the completion of nuclear division (Bonassi and 
Au 2002) (see Figure 2). In contrast with the CA test, the MN assay/
test is able to detect aneugenic events, one of the major advantages of 
the MN assay (Albertini et al. 2000). In addition, MN can be assessed 
much more easily, quickly, and objectively than CAs in metaphase cells 
using the traditional CA assay. In practice, it is possible to score thou-
sands instead of hundreds of cells per treatment or subject, which leads 
to a greater accuracy of the test. It is nowadays possible to use automated 
methods for micronucleus analysis (Decordier et al. 2011; Rossnerova 
et al. 2011). Furthermore, structural and numerical chromosome muta-
tions are implicated in many human genetic diseases and are involved in 
the induction or progression of cancer (Kirsch-Volders et al. 2000). On 
the other hand, since cells need to survive at least one nuclear division 
for micronucleus formation, some damaged cells may not be detected 
because they have been lost or unable to divide (Bonassi and Au 2002).
Figure 2. Examples of micronuclei (arrow) in Giemsa-stained binucleate 
human lymphocytes. The size of the micronuclei varies. Photographs kindly 
provided by Hilkka Järventaus.
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The analysis of MN has been used to quantify exposure to genotoxic 
chemicals and radiation in a large number of studies. MN can be ob-
served in almost any cell type, and for this reason many variations of the 
assay exist. Micronucleus analysis is employed in studies with humans 
and laboratory animals following in vivo or in vitro exposures (Tucker 
and Preston 1996). One could say that the use of MN as an indicator of 
(Kirsch-Volders et al. 2000) chromosomal damage has become a stand-
ard assay in both genetic toxicology and human biomonitoring studies.
Although the association between the frequency of MN and long-
term biological consequences such as cancer has not fully been elucidated 
yet, a potential predictive role for this biomarker has been suggested 
on theoretical grounds (Fenech et al. 1999). Early investigations of 
micronucleus frequency (MN frequency) and cancer risk suggested 
no association (Brøgger et al. 1990; Hagmar et al. 1998; Bonassi et al. 
2000). However, these data were based on heterogeneous methods for 
micronucleus detection, young cohorts, and relatively short follow-up. 
Recent studies, based on a single micronucleus technique (CBMN as-
say) have indicated that MN frequency may predict overall cancer in 
a similar way as CA frequency does (Bonassi et al. 2006; Bonassi et al. 
2007; Bonassi et al. 2011). The baseline frequency of MN appears to be 
elevated in untreated cancer patients (Iarmarcovai et al. 2008).
Micronucleus assay in genotoxicity testing
The MN assay was used for the first time in vitro in radiation experiments 
with roots of Vicia faba in 1959 (Evans et al. 1959). Micronucleus tests in 
plants, such as in root tips cells of Allium cepa and Vicia faba or in pollen 
mother cells of Tradescantia has been used especially in environmental 
monitoring (Grant 1994; Rodrigues et al. 1997).
In the early seventies, Schmid (1975) used micronucleus analysis in 
bone marrow erythrocytes of mice as a technique to study the genotoxic-
ity of various exposures in vivo. Since 1983, the erythrocyte micronucleus 
test (MN test) has been included in OECD test guidelines and is the 
most frequently used in vivo assay for routine genotoxicity screening of 
chemicals (OECD 1997). Depending on exposing agent, the erythro-
cyte MN test is indicative of exposure during the last 24–48 h in bone 
marrow and 36–72 h in peripheral blood.
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Countryman and Heddle (1976) were the first to introduce a MN 
assay for cultured human cells. The in vitro MN test has been validated 
for genotoxicity testing (Corvi et al. 2008), and a guideline on “In 
vitro Mammalian Cell Micronucleus Test” was recently adopted among 
OECD test guidelines (OECD TG 487) (OECD 2010). The application 
of the CBMN assay for in vitro genotoxicity testing has been discussed 
extensively (Kirsch-Volders, Elhajouji et al. 1997; Kirsch-Volders, Sofuni 
et al. 2000; Kirsch-Volders, Sofuni et al. 2003; Corvi, Albertini et al. 
2008).
Micronuclei in biomonitoring studies
The employment of the MN test for human biomonitoring studies was 
first described by Meretoja and Vainio (1979) who examined MN in 
ordinary cytogenetic preparations of cultured lymphocytes of styrene-
exposed subjects. A few years later, Stich and co-workers (Stich et al. 
1982) proposed that MN could be used to study genotoxic effects in all 
human tissues from which it is possible to obtain exfoliated cells. Since 
then, investigations with cells from buccal and nasal mucosa, esopha-
gus, bronchi, urinary bladder, and cervix have been performed (Majer 
et al. 2001; Huvinen et al. 2002; Thomas et al. 2011). Most studies on 
exfoliated epithelial cells have though utilized buccal and nasal mucosa 
(Sarto et al. 1987; Lucero et al. 2000).
Nevertheless, the most common cell types examined for MN are those 
of the haema topoietic system, especially peripheral blood cells, because 
they are readily attainable in humans. The examination of bone marrow 
and other human internal tissues is technically possible but, because of 
the invasive sampling, not commonly utilised (Tucker and Preston 1996). 
Thus, due to the easy availability of peripheral lymphocytes, they are 
frequently used in biomonitoring. Peripheral differentiated lymphocytes 
that circulate everywhere in the body are regarded to imitate exposure in 
general but are not considered as immediate targets for carcinogenesis. 
They are in a way examined as a surrogate tissue for other tissues where 
cancer can develop. This assumption is based on the theory that similar 
genotoxic damage occurs in cancer-prone tissue and in the circulating 
peripheral lymphocytes. Lymphocytes may not well illustrate exposure 
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to substances of which the effect is at the point of entry into the body, 
for example at the upper airways, or which have special target tissue, 
e.g., due to organ-specific metabolism (Norppa 2004a).
The last few years have seen a strong increase in the use of the MN 
assay as a tool to biomonitor human genotoxic exposure and effects. 
A recent overview covering the last 25 years and reviewing population 
studies performed utilizing cytogenetic biomarkers (Bonassi et al. 2005), 
found 434 papers where MN had been used as an endpoint. A wide 
variety of exposures to chemicals and ionizing radiation were covered in 
these papers. Organic chemicals were by far the most commonly studied 
exposure. The most frequently examined compounds of this group were 
styrene, polyaromatic hydrocarbons (PAHs), benzene, ethylene oxide, 
and formaldehyde. Among inorganic chemicals chromium, arsenic, 
lead, and mercury were mostly studied. Several papers also addressed 
radiation exposure.
Furthermore, occupational exposure of pesticides has been exam-
ined in a number of papers. The use of pesticides in agriculture usually 
involves complex exposure to mixtures of pesticides which may contain 
genotoxic ingredients. A comprehensive review of the literature dealing 
with genotoxic effects in human groups exposed to pesticides (Bolognesi 
2003) indicated that such a work is often associated with an increase 
in genotoxic damage depending on the degree and type of exposure. A 
positive association between occupational exposure to complex pesticide 
mixtures and an increase in MN, CAs and SCEs has been detected in 
the majority of studies, although a number of studies also failed to detect 
cytogenetic damage. An increase in MN frequency in workers with oc-
cupational exposure to pesticides was observed by several investigators 
(Bolognesi et al. 1993a; Bolognesi et al. 1993b; Joksic et al. 1997; Bo-
lognesi et al. 2002; Garaj-Vrhovac and Zeljezic 2002). Others reported 
negative micronucleus results (Scarpato et al. 1996a; Davies et al. 1998; 
Venegas et al. 1998; Lucero et al. 2000; Pastor et al. 2003).
The ability to detect both clastogenic and aneugenic effects is an 
advantage of the micronucleus technique (Kirsch-Volders et al. 1997; 
Fenech 2000). The distinction between the two phenomena, by iden-
tifying the origin of MN, is important, whether micronucleus analysis 
is used for genotoxicity testing or biomonitoring of genotoxic exposure 
and effect in humans (Thomson and Perry 1988; Eastmond and Tucker 
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1989; Becker et al. 1990; Norppa et al. 1993; Norppa et al. 1993). For 
an optimal sensitivity of the assay, the MN deriving from chromosomal 
fragments and the whole chromosome-containing MN needs to be 
identified (Norppa and Falck 2003).
Micronuclei in lymphocytes – methodological 
aspects
MN are expressed in cycling eukaryotic cells that have completed nuclear 
division, which makes the MN assay quantitatively unusable in non-
dividing cell populations. In order to control the effect of cell division 
kinetics on MN frequency, development of a method that makes it 
possible to distinguish non-dividing cells from mitotic (dividing) cells 
in a cell population was necessary. In the case of cultured lymphocytes, 
MN should be analyzed from cells that have completed only one in vitro 
division after the in vivo exposure studied. The main reason for this is 
that most induced MN are assumed to be formed in the first division 
following the genotoxic exposure. Although reappearance of MN in sub-
sequent division has been observed in live cell imaging studies (Huang 
et al. 2011), it is unclear how frequently this could occur.
The CBMN assay, originally described in 1985 for human lym-
phocytes by Fenech and Morley (Fenech and Morley 1985; Fenech and 
Morley 1986) is a method that enables the identification of cells that 
have divided once. The method has widely been used as a sensitive and 
reliable technique for assessing chromosome damage in humans (Fenech 
2000; Fenech et al. 2003). The assay has been utilized for both moni-
toring chromosome damage in human populations and in vitro testing 
of genotoxicity (Fenech 1993; Kirsch-Volders 1997; Kirsch-Volders et 
al. 1997).
In the CBMN assay, cytokinesis is blocked by adding Cyt-B to the 
cell cultures (Fenech and Morley 1985). Cyt-B, an inhibitor of actin 
polymerization, inhibits the formation of the microfilament ring that 
constricts the cytoplasm between the daughter nuclei during cytokinesis 
(Carter 1967). In the presence of Cyt-B, the stimulated lymphocytes 
that have divided are identifiable as binucleate cells which are easily 
distinguished from mononucleated, non-dividing cells. MN are scored 
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in binucleated cells only (see Figure 2) and the number of micronucle-
ated binucleate cells (MNBNCs) is assessed. The concentration of Cyt-B 
should generally be minimized but still allowing a maximum amount 
of binucleated cells: 6 µg/ml of Cyt-B is recommended for whole-blood 
lymphocyte cultures and 3–6 µg/ml for cultures of isolated lymphocytes 
(Kirsch-Volders et al. 2000). At 72 h after initiation of culture and PHA 
stimulation, optimal culture conditions should give 35–60% or more 
binucleates as proportion of viable cells (i.e. all cells excluding necrotic 
and apoptotic cells) (Fenech 2000). The CBMN technique enables 
comparisons of chromosome damage between cell populations that 
may differ in their cell division kinetics (Fenech 2000). Technically, 
binucleate cells can be visualized by the traditional Giemsa staining or 
with DNA fluorochromes (Norppa et al. 1993; Surralles et al. 1995; 
Fenech 2000; Norppa and Falck 2003); the fluorescence techniques can 
be complemented by fluorescence in situ hybridization (FISH) (Norppa 
et al. 1993) or anti-kinetochore staining (Eastmond and Tucker 1989) 
for the identification of MN contents. The advantages of the two latter 
methods are clear when the mechanism of MN formation is assessed 
(Kirsch-Volders et al. 1997; Norppa and Falck 2003).
Another possibility to identify DNA synthesizing cycling (e.g. divid-
ing) cells in culture is to use 5-bromodeoxyuridine (BrdU) labeling of 
DNA. BrdU is a DNA base analogue BrdU which is incorporated in the 
place of thymine when the cell divides. The presence of incorporated 
BrdU can be detected with immunofluorescence or immunocytochemi-
cal detection methods (Norppa et al. 1990; Montero-Montoya et al. 
1997). BrdU-labeling followed by Giemsa staining (without using BrdU 
antibodies) has earlier been used for human lymphocytes by Pincu 
et al. (1984), Fenech et al. (1988), and Brenner et al. (Brenner, Jeffrey 
et al. 1991). As this technique does not exclusively identify cells that 
have completed nuclear division, some BrdU-labelled cells may still be 
in S or G2 phase.
Mechanisms of micronucleus formation
For several years already, it has been well established that several dif-
ferent mechanisms can be involved in the formation of MN (Heddle 
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et al. 1983). A general assumption is that MN are formed from whole 
chromosomes or chromosomal fragments that lag behind in anaphase, 
and that cell division is prerequisite for MN formation. A MN con-
taining chromosome fragments may result from direct double-strand 
DNA breaks (DSB), conversion of single-strand DNA breaks (SSBs) to 
DSBs after cell replication, or inhibition of DNA synthesis. Misrepair 
of DNA lesions in two chromosomes may result in an asymmetrical 
chromosomal rearrangement forming a dicentric chromosome and an 
acentric fragment (AF); in cell division, the centromeres of the dicen-
tric chromosomes may be pulled towards opposite poles, forming a 
nucleoplasmic bridge (NPB) between the daughter nuclei with the AF 
that laging behind and becoming a micronucleus (Thomas et al. 2003; 
Fenech 2005; Mateuca et al. 2006; Pampalona et al. 2009). MN may 
also be created from (multiple) breaks in anaphase bridges originally 
formed from dicentric chromosomes, concatenated ring chromosomes, 
union of sister chromatids, unresolved sister chromatid connections, or 
chromosomes joined by telomere associations (Gisselsson et al. 2000; 
Hoffelder et al. 2004; Pampalona et al. 2009). 
Defects in the chromosome segregation machinery, such as deficien-
cies in cell cycle controlling genes, spindle disturbances, kinetochore, and 
dysfunction of other components of the mitotic apparatus, or damage 
to chromosomal substructures, mechanical disruption (Albertini et al. 
2000), and hypomethylation of centromeric DNA (Crott et al. 2001; 
Fenech 2001; Fenech et al. 2005; Mateuca et al. 2006) are also thought 
to be the essential events in micronucleus formation. 
This may not, however, apply to all situations. MN may also derive 
from gene amplification through breakage-fusion-bridge cycles when 
amplified DNA at the nuclear periphery is eliminated by nuclear budding 
during the S-phase of the cell cycle (Fenech 2002). In tumor cells, e.g. 
liposarcoma (WDLPS) (Pedeutour et al. 1994) and colorectal carcinoma 
(COLO 320DM tumor cell line) (Shimizu et al. 1998; Shimizu et al. 
2000), MN has been suggested to derive from nuclear buds, without 
cell division. Using transformed cell lines, Shimizu et al. (Shimizu et al. 
1998; Shimizu et al. 2000) also showed that amplified DNA is localized 
selectively to specific sites at the periphery of the nucleus and eliminated 
via nuclear budding to form MN during the S phase of the cell cycle. 
Nuclear buds, as potential precursors of MN, are morphologically simi-
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lar to MN with the exception that they are joined to the nucleus by a 
thin nucleoplasmic connection (Fenech and Crott 2002) (see Figure 3). 
According to the conventional model of micronucleus formation, 
nuclear buds, may also derive from anaphase laggards that independ-
ently form a nuclear envelope before fully integrating into the nucleus 
(Serrano-Garcia and Montero-Montoya 2001) or from remnants of 
broken anaphase bridges (Gisselsson et al. 2000; Lindberg et al. 2007; 
Pampalona et al. 2009).
Figure 3. Examples of nuclear buds (arrow) connected by thin treads to the 
main nuclei in human lymphocytes blocked with Cytochalasin-B. Photgraphs 
kindly provided by Hilkka Järventaus.
detection of micronucleus contents
Previously, analysis of MN provided little or no information concerning 
the type of damage involved in their formation. Some researchers con-
sidered that the size of MN could tell about the type of damage. Larger 
MN were more likely to be caused by spindle damage and to contain 
whole chromosomes or chromatids, while smaller MN could consist of 
one or more chromosome fragments (Yamamoto and Kikuchi 1980; 
Tucker and Preston 1996). MN containing entire chromosomes have 
also been characterized by C-Banding (Verschaeve et al. 1988; Van Hum-
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melen and Kirsch-Volders 1992) and by measurement of DNA content 
(Vanderkerken et al. 1989; Grawe et al. 1994) of the MN.
One solution to this problem has been to use molecular methods to 
identify the contents of MN. The techniques are of two general types: 
those that use antikinetochore antibodies and those that use centromeric 
DNA probes. Unique sequence DNA probes and probes detecting re-
petitive DNA for a single chromosome can also be utilized to examine 
the contents of MN.
Centromere and kinetochore identification has successfully been used 
in numerous in vitro and in vivo studies to examine the contents of MN 
(Norppa et al. 1993; Norppa and Falck 2003). Information on the more 
detailed composition of MN is limited, but there are clear indications 
that different chromosomes are micronucleated nonrandomly. Interest-
ingly, several studies have shown that the X chromosome appears in 
MN of females and the Y in MN of males far more often than expected 
by chance (Guttenbach et al. 1994; Hando et al. 1994; Richard et al. 
1994). It is important to realize that our knowledge of the contents of 
MN is still scarce. Yet, understanding what MN actually consists of is 
a basic requirement for the correct use of the MN assay (Norppa and 
Falck 2003).
Antikinetochore antibodies, deriving from the serum of scleroderma 
CREST (Calcinosis, Raynaud’s phenomenon, Esophageal dysmotility, 
Sclerodactyly and Telangiectasia) patients (Moroi et al. 1980), bind to 
chromosomes at the site of spindle fiber attachment, and thus serve as a 
marker for the centromeric region. The bound antikinetochore antibod-
ies can be detected by immunofluorescence or immuno histochemistry 
(Hennig et al. 1988; Thomson and Perry 1988; Eastmond and Tucker 
1989; Fenech and Morley 1989). MN with a kinetochore signal (K+) 
are considered to contain whole chromosomes or chromatids and are 
thus indicative of events that disturb the mitotic apparatus and result 
in chromosome lagging at anaphase (Hennig et al. 1988; Thomson and 
Perry 1988; Eastmond and Tucker 1989). Kinetochore-negative MN 
(K-), on the other hand, indicate clastogenic processes (Eastmond and 
Tucker 1989).
Centromeric DNA probes have been used to make similar determi-
nations (Becker et al. 1990; Norppa et al. 1993; Titenko-Holland et al. 
1994). The occurrence of an entire chromosome (or chromatid) in MN 
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can be shown by a DNA probe that recognizes complementary centro-
meric DNA sequences (Ford et al. 1988; Becker et al. 1990; Migliore et 
al. 1993; Norppa et al. 1993) in a centromere-positive (C+) MN. MN 
with acentric fragments are not expected to contain centromeric DNA 
and are centromere-negative (C-).
The two main classes of MN are usually distinguished from each 
other by DNA probes hybridizing to alpha satellite DNA present on all 
human chromosomes. Alpha satellite DNA is characterized by a diverged 
171-base-pair motif repeated in a tandem fashion (Schueler et al. 2001; 
Tsuchiya et al. 2001). The pancentro meric DNA probes used for MN 
characterization have been cloned alphoid probes (Becker et al. 1990; 
Thierens et al. 1999), oligonucleotides with an alphoid consensus se-
quence (Norppa et al. 1993; Elhajouji et al. 1995; Darroudi et al. 1996), 
commercially available probes for all human centromeres (Migliore et 
al. 1993; Titenko-Holland et al. 1994; Doherty et al. 1996), or alpha 
satellite probes prepared by polymerase chain reaction (Huber et al. 
1996). Fluorescence in situ hybridization (FISH) with digoxygenin- or 
biotin-labeled DNA probes detected by antibodies conjugated with 
fluorescein or other appropriate fluorescence labels has commonly been 
used in several studies. Nowadays, DNA probes directly labeled with 
a fluorochrome are mostly used. Immunohistochemical detection by, 
e.g., alkaline phosphatase or peroxidase has been used in some papers 
(Guttenbach et al. 1994; Nardone 1997; Vral et al. 1997). In princi-
ple, centromeric DNA can also be detected by primed in situ labeling 
(PRINS) (Russo et al. 1996; Basso and Russo 2000), but this technique 
appears not to have been applied for human MN.
Schuler et al. (1997) have reviewed the advantages and disadvantages 
and technical aspects of the CREST and FISH methods in characterizing 
MN. Fragments with break point at the centromere may form C+ MN if 
the breakage destroys centromere function. True centric fragments with 
a complete centromere are expected to be rare in MN of non-cancerous 
cells, as they should normally be attached to the spindle, unless they lack 
a functional kinetochore. It is also possible that a MN contains both 
one or more fragments and one or more chromosome; in this case, the 
detection of centromeric DNA would only suggest the presence of the 
latter. In general, MN deviating from the two simple categories (acentric 
fragment vs. chromosome) should in most cases be relatively rare in non-
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cancerous cells. They would either require an inducer with a very specific 
mode of action or the simultaneous occurrence of two or several (more 
or less) independent events whose combined probability should be low.
MN formed from entire chromosomes with a disrupted or detached 
kinetochore may result in MN with no kinetochore signal (Schuler et 
al. 1997). This appears to be a real problem for the use of kinetochore 
identification in human biomonitoring and studies of spontaneous MN, 
since a considerable portion of MN harboring the centromere of X or Y 
chromosome seem to be kinetochore-negative (K-) (Hando et al. 1994; 
Nath et al. 1995; Tucker et al. 1996; Hando et al. 1997). Kinetochore 
defects may be common for the micronucleation of other chromosomes 
as well, but even the X chromosome alone is expected to give rise to 
errors in the assessment of MN contents using kinetochore antibodies, 
since this single chromosome may account for 70% of MN in binucle-
ate lymphocytes of women (Hando et al. 1994; Hando et al. 1997). In 
practice, centromere and (with some reservation) kinetochore detection 
can be expected to be accurate enough in distinguishing the two main 
types of MN in experimental studies, but it appears that centromeric 
FISH should be recom mended for studies of human exposure and 
spontaneous MN levels, due to the low prevalence of kinetochore label 
in MN harboring entire sex chromosomes (Norppa and Falck 2003).
Chromosome-specific centromeric DNA probes have been used to 
identify the presence of specific chromosomes in MN by FISH (Gut-
tenbach and Schmid 1994; Hando et al. 1994; Richard et al. 1994; 
Catalán et al. 1995; Tucker et al. 1996; Hando et al. 1997; Acar et al. 
2001; Bakou et al. 2002). The use of a pancentromeric probe, an X-
chromosome-specific centromeric probe, and (in men) a Y-chromosome-
specific centromeric probe allows one to estimate the contribution of 
acentric fragments, X-chromosomes, Y-chromosomes, and autosomes 
in MN (Cafiero et al. 1989; Catalán et al. 1995; Surralles et al. 1996; 
Catalán et al. 1998).
The involvement of all human chromosomes in MN has been studied 
by chromosome painting (Fauth et al. 1998; Fauth and Zankl 1999; 
Fauth et al. 2000) and spectral karyotyping (Komae et al. 1999; Leach 
and Jackson-Cook 2001); coupled with centromeric probes this approach 
can distinguish between MN harboring centric and acentric DNA de-
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rived from specific chromosomes (Lindberg et al. 2007; Lindberg et al. 
2008; Pacchierotti and Sgura 2008; Attia 2009; Pampalona et al. 2009).
If micronucleation of chromosomes is random, each single human 
chromosome should be present in 2.17% (1/46) of chromosomes-
containing MN. However, studies using the FISH method have shown 
that different human chromosomes are non-randomly micronucleated. 
Especially, in cultured human lymphocytes, the increase in centromere-
containing micronuclei with ageing has primarily been attributed to 
micronucleation of the X and Y-chromosomes due to increasing age (Gut-
tenbach et al. 1994; Hando et al. 1994; Richard et al. 1994; Catalán et 
al. 1995; Zijno et al. 1996; Zijno et al. 1996; Bakou et al. 2002). These 
findings are supported by age-dependent loss of X and Y chromosomes 
(Stone and Sandberg 1995; Catalán et al. 1998; Song et al. 2009).
Key factors affecting the baseline level of 
micronuclei in lymphocytes
MN frequency in lymphocytes is known to be affected by age, gender 
and multiple dietary and lifestyle factors (Fench and Bonassi 2011). 
Many studies have shown that chromosomal damage increases progres-
sively with age (Fenech et al. 1994; Ramsey et al. 1995; Bolognesi et al. 
1997; Bolognesi et al. 1997; Wojda and Witt 2003). The reasons for 
the increase are unclear. In addition to age, several other factors may 
affect the baseline level of chromosome alterations. By understanding 
the contribution of biological variation, diet, lifestyle, and genetic back-
ground to spontaneous chromosomal damage rate, it would presumably 
be easier to detect the effect of environmental exposures (Fenech 1998).
Biological variation
It is important to recognize the variables that can affect the frequency 
of MN when selecting donors for a study on MN in an occupationally 
exposed group. It is known that biological factors such as age, gender, 
and genetic background can influence the baseline frequency of MN. 
Lower spontaneous MN frequencies are found in healthy, nonsmoking 
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young adults (Kirsch-Volders et al. 2000). A twin study indicated more 
similar MN frequencies in monozygotic twins than dizygotic twins, 
indicating a strong influence of genetic factors have on baseline MN 
frequencies (Surowy et al. 2011).
The most consistent biological variables influencing the micronucleus 
index (MN index) in lymphocytes are gender and age. According to 
Fenech (Fenech 1998), MN frequencies are generally 1.2 to 1.6 times 
higher in females than in males. Furthermore, MN frequencies increase 
steadily and significantly with age in both sexes, but the linear regres-
sion slope is steeper in females (Fenech 1998). In order to verify the 
influence of age, gender and several other variables (e.g. experimental 
factors) affecting the observed micronucleated cell (MNC) frequency 
in experiments performed with the CBMN technique, a database of 
almost 7000 subjects, from 25 laboratories from 16 several countries was 
analyzed in context with the HUMN project (HUman MicroNucleus 
project, on the web: http://ehs.sph.berkeley.edu/holland/humn/; Fenech 
et al. 2011). An increase in MNC frequency with age was evident in 
almost all laboratories. The effect of gender was also present - females 
had higher levels of MNCs (19%). The analysis of the pooled data from 
the laboratories using the CBMN assay indicated that MNC frequency 
increases with age in both genders, with the steepest increase after 30 
years of age, and to a higher level in females (Bonassi et al. 2001).
Besides age, there may be other sources of inter-individual and intra-
individual variation over time. In most studies, only one MN measure-
ment is performed for each individual. It can be argued how well MN 
level obtained from a single measurement can reflect the overall genetic 
damage rate for the individual, because it is not clear if the MN index 
varies with season. Investigations for CAs have suggested that chromo-
some damage can be influenced by season (Anderson et al. 1991). It 
has been suggested that CA and MN frequencies fluctuate over time 
depending on the exposure pattern of the subjects (see Bonassi et al. 
2005). This might particularly concern chromatid-type CAs and MN 
derived from CAs that arise ex vivo (when the lymphocytes are cultured) 
from DNA damage pre-existing in the peripheral lymphocytes (Alber-
tini et al. 2000). However, MN determinations repeated every three 
months showed a strong correlation between the repeat measurements 
and no significant seasonal effect (Fenech 1998). In principle, many of 
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the MN visible in cultured lymphocytes are expected to be formed in 
the first in vitro division. It was recently reported that cancer patients 
who had received varying regimens of cytostatics, including aneugens, 
showed a clearer increase in micronucleted binucleate and mononucleate 
lymphocytes after 72 h of culture than in mononucleate cells after 24 
or 48 h of culture (Arsoy et al. 2009). Most of the induced MN were, 
however, large and contained several C+ signals. These findings appeared 
to suggest that the therapy-induced MN were primarily formed ex vivo 
from persistent damage through a complex mechanism.
Individuals may differ in their sensitivity to Cyt-B and to the concen-
tration of Cyt-B used which is usually between 3 and 6 µl/ml. Reports 
from different laboratories also show that binucleate cell frequencies vary 
considerably, which may reflect both biological and technical variation. 
Much of this variability is probably due to inter-individual variation in 
lymphocyte cultures as concerns mitogen stimulation and cell growth 
(Bonassi et al. 2001); age is one of the key variables associated with 
reduced number of dividing cells in lymphocyte cultures.
dietary variables
Diet is a presumptive key factor in determining genomic stability and 
probably more important than has been believed before. Nutrition anti-
oxidants are also believed to play an important role in cellular antioxida-
tive defence. The impact of diet and vitamin status on MN index has 
been examined in a couple of cross-sectional and randomized placebo-
controlled intervention studies (Fenech 1996). When vegetarians/vegans 
and non-vege tarians were compared, no significant difference in the 
age-dependent slope of MN index between these groups was detected 
(Fenech and Rinaldi 1994). In men, MN index was significantly lower 
in the 20–40 years age group among non-vegetarians than in the 41–60 
years age group among vegetarians. 
The main nutritional factors influencing MN index in persons who 
were not folate deficient were the levels of vitamin B12 and homocysteine 
in the plasma (Fenech 1996). Folate is an essential B-vitamin that occurs 
naturally in miscellaneous food, such as broccoli, cabbage, cauliflower, 
fruits and nuts. Mammals are unable to synthesize folate de novo and 
are, therefore, obliged to receive it from dietary sources (Beetstra et al. 
34
REVIEW OF THE LITERATURE
2005). Folate plays a critical role in the prevention of chromosome 
breakage and hypomethylation of DNA (Fenech and Ferguson 2001; 
Wang and Fenech 2003; Fenech 2005). Both in vitro and in vivo studies 
with human cells show that folate-, and vitamin B12-deficiency as well 
as elevated plasma homocysteine are associated with expression of chro-
mosomal fragile sites, chromosome breaks, excessive uracil in DNA, MN 
formation, and DNA hypo methylation (Jacky et al. 1983; Everson et al. 
1988; Blount and Ames 1995; Blount et al. 1997; Duthie and Hawdon 
1998; Fenech 1998; Titenko-Holland et al. 1998; Ames 1999; Crott et 
al. 2001; Fenech 2002; Fenech 2002; Smolkova et al. 2004; Lindberg 
et al. 2007). Furthermore, DNA breaks in human cells are minimized 
when folic acid concentration in culture medium is greater than 180 
nmol/l (80 ng/ml) (Jacky et al. 1983; Duthie and Hawdon 1998). The 
exact mechanisms by which low folate influences micronucleation rate 
is not known, but it probably occurs through increased incorporation 
of uracil into DNA or hypomethylation of DNA. It appears that folate 
deficiency increases MN harboring chromosomal fragments and MN 
harboring whole chromosomes (Lindberg et al. 2007). Besides low folate, 
low intake of calcium, nicotinic acid, vitamin E, retinol, beta-carotene 
and high intake of pantothenic acid, biotin and riboflavin were associ-
ated with increased frequencies of lymphocyte MN (Fenech et al. 2005). 
Intervention studies suggest that multiple micronutrient combinations 
are more effective (at normal levels of folate and B12) than individual 
micronutrients in reducing MN frequency (Thomas et al. 2011).
It can be expected that diet containing natural mutagens or those 
generated in the processing of food (e.g., heterocyclic amines) results 
in increased genotoxic damage that could possibly also be seen in the 
MN level. However, in mice, 3–6-month consumption of cooked meat 
did not increase the frequency of MN in spleen lymphocytes (Fenech 
and Neville 1993). Recent data suggest that the non-alcoholic fraction 
of red wine decreases gamma-radiation-induced micronuclei in human 
lymphocytes, apparently by protecting DNA from oxidative damage 
(Greenrod et al. 2005).
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Experimental variation
One important factor assumed to affect the baseline level of MN is ex-
perimental variation. There seems to be some inter-laboratory variation in 
baseline MN frequencies, which could reflect methodological differences 
in cell culture techniques, specimen preparation, and staining among the 
laboratories. For instance, most laboratories use RPMI 1640 medium 
(Surralles and Natarajan 1997) in their experiments, while some groups 
use modified McCoy’s culture medium. These culture media differ in 
compo sition; particularly with respect to some vitamins (Ascorbic acid, 
Folic acid and Vitamin B12, which are present at higher concentrations 
in McCoy’s medium). However, scoring of MN in 23 healthy persons, 
cultured in the two different types of media did not reveal any significant 
effect of culture media on the baseline MN frequencies (Fenech 1998). 
Slide preparation and staining of cells can be performed in several 
ways. Since the quality of the slide preparation and staining influences 
the analysis, it is important to use the most accurate methods. In fixa-
tion and slide preparation, the cytoplasm and the boundaries of the 
cells should be preserved and cell clumping minimized (Kirsch-Volders 
et al. 2000). Several staining methods have been used but fluorescence 
DNA dyes may be preferred (Kirsch-Volders et al. 2000), since they en-
able detection of very small MN more easily than for instance Giemsa 
(Surralles et al. 1995).
Many studies have shown that both sampling error and error in scor-
ing the slides is a major source of variation for the MN assay. These errors 
can be reduced by allowing only experienced scorers to do the work. An 
important contributor to the scoring error is the inter-scorer variability. 
The difference between scorers has been noted to vary by a factor of 1.6 
(Fenech 1998). Inter-scorer variability is naturally avoided if only one 
scorer is involved. If several scorers are used, the impact of inter-scorer 
variability can be mini mized by each scorer analyzing the same number 
of (different) cells from all samples (the coefficient of variation among 
the scorers can be reported). Within an experiment, variation between 
cultures is usually reduced by including duplicate or triplicate cultures 
(Fenech 1998). Automation of MN analysis is expected to reduce vari-
ation in MN scoring (Decordier et al. 2011; Rossnerova et al. 2011). 
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Aneuploidy in somatic cells
An unequal distribution of the sister chromatids during the division of cell 
nuclei (as well as during mitosis and meiosis) produces aneuploid daughter 
cells (Cimini et al. 2001). Aneuploidy can thus be defined as a deviation 
from the normal (euploid) chromosome number of a cell or an individual. 
Euploidy can be described as the condition of having a normal number of 
structurally normal chromosomes. In humans, the normal chromosome 
number is 46 which consist of 44 autosomes and two sex chromosomes. 
Thus, euploid human females have two X chromosomes and males an X 
and a Y chromosome. To maintain genome integrity accurate chromosome 
segregation during mitosis and meiosis is crucial. An unequal distribution 
of chromosomes leads to a gain or loss of chromosomes in the daughter 
cells forming aneuploid cells (Hegarat et al. 2005).
Aneuploidy can be induced by different mechanisms: 1) failure of 
chromosome attachment to the mitotic spindle, 2) monotelic attachment 
(single kinetochore attachment to one pole), 3) merotelic attachment 
(single kinetochore attachment to both poles), 4) syntelic attachment 
(both sister kinetochores attach and migrates to the same mitotic pole) 
and 5) premature sister chromatid separation (Cimini et al. 2001; Cimini 
et al. 2003; Salmon et al. 2005). Aneuploid cells with hypoploid (loss) 
or hyperploid (gain) chromosome numbers arise when chromosomes 
fail to segregate properly during mitosis. Several studies have shown a 
significant increase in chromosome loss, primarily of the sex chromo-
somes, in peripheral blood lymphocytes and skin fibroblasts in both 
males and females of advanced age (Jacobs et al. 1961; Fitzgerald and 
McEwan 1977; Richard et al. 1993; Stone and Sandberg 1995). Some 
other studies have, however, suggested that the frequency of autosomal 
loss (hypoploidy) and autosomal gain (hyperploidy) is not necessarily 
a function of age or gender (Nowinski et al. 1990; Hando et al. 1994). 
Aneuploidy is the most frequently observed type of cytogenetic abnor-
mality. It can be induced by chemical action upon the cell. The cellular 
targets can be those involved in cell division as well as the chromosomes 
themselves (Parry and Parry 1989). Many known chemical aneuploidog-
ens (or aneugens) exist (Parry et al. 1996; Kirsch-Volders et al. 2002), 
and aneugenic effects are used as a criterion in carcinogen classification 
(Bolt et al. 2004).
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Incorrect segregation of the chromosomes into the daughter cells 
is also a major cause of human reproductive failure and an important 
contributor to cancer. The two major causes of aneuploidy are chromo-
some loss and non-disjunction. The different mechanisms leading to 
chromosome loss and non-disjunction can be investigated by the analysis 
of morphological and structural changes in the cell division apparatus by 
the application of specific stains and antibodies for various cell division 
components (Parry et al. 2002). Non-disjunction of chromosomes at 
anaphase gives a trisomic daughter nucleus and a monosomic daughter 
nucleus. On the other hand, chromosome loss from the nucleus during 
cell division produces a mono somic daughter nucleus and a normal 
daughter nucleus. In the latter case, the lost chromosome may form a 
MN that can be cytogenetically detected. The micronucleus may also 
be randomly re-incorporated into either one of the daughter nuclei 
producing trisomic and monosomic daughter cells (Parry et al. 2002) 
or be dispelled from the cell.
Aneuploid lymphocytes increase with age. In women this mainly 
concerns the loss of the X chromosome (Jacobs et al. 1961; Fitzgerald 
and McEwan 1977; Richard et al. 1993).
detection of aneuploidy in interphase nuclei
By the application of FISH with chromosome-specific centromeric DNA 
probes, direct analysis of aneuploidy in a large numbers of interphase 
nuclei can be performed. This approach can in principle be applied to 
any type of human cells, and the cells do not need to be cycling at the 
moment of the analysis to reflect chromosome loss or gain that have 
occurred when the cells divided. In mononucleate cells, it cannot usu-
ally be judged if the aneuploidy observed derived from non-disjunction 
or chromosome loss and if it occurred during the previous or an earlier 
division. However, if cultured cells are studied, the cytokinesis-block 
technique can be used. In binucleated cells, both of the daughter nuclei 
are retained, and the probable origin of a specific aneuploidy can be as-
sessed (Eastmond and Pinkel 1990; Eastmond et al. 1995; Zijno et al. 
1996). In many studies, this technique has been used to determine the 
frequency of aneuploidy as a function of age, cancer, folate deficiency, or 
in vitro treatments with suspected or known aneuploidogens (Eastmond 
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and Pinkel 1990; Eastmond et al. 1995; Zijno et al. 1996; Ramirez et 
al. 1997; Carere et al. 1999; Migliore et al. 1999; Leopardi et al. 2002; 
Wang et al. 2004; Camps et al. 2005).
Metabolic polymorphisms of importance in 
biomonitoring
A multitude of enzymes, capable of using foreign chemicals (xenobiotics) 
as substrates, carry out xenobiotic metabolism in vivo, leading to either 
decreased or increased toxicity. Most xenobiotics that enter the body are 
lipophilic, which enables them to penetrate lipid membranes and to be 
transported by lipoproteins in the blood. Xenobiotic metabolism consists 
of two phases. In phase one; a polar reactive group is introduced into 
the molecule, forming a suitable substrate for the phase-two enzymes. 
Cytochrome P-450 (CYP) monooxygenases are typical phase-one en-
zymes responsible for the metabolic activation of a number of indirect 
carcinogens. The phase-two enzymes bring about the conjugations of 
xenobiotics to various endogenous substrates such as sugars, amino acids, 
and so on, forming water-soluble products that are more easily excreted. 
In general, this process is a detoxification sequence, even if in some cases 
reactive intermediates may be formed that are much more toxic than the 
parent compound (Hodgson 1997).
Many xenobiotic-metabolizing enzymes (XMEs) functioning in the 
metabolic activation or detoxification of carcinogens have been shown 
to be polymorphic due to single nucleotide changes or other genetic 
alterations in the genes coding for the enzymes, resulting in, e.g., altered 
enzyme activity or stability. Several of such genetic polymorphisms have 
been associated with cancer risk (Bonassi and Au 2002; Au and Salama 
2005; McIlwain et al. 2006; Agundez 2008; Dong et al. 2008), and 
some of them also appear to influence the level of cytogenetic biomark-
ers (Norppa 2004b; Iarmarcovai et al. 2008).
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Glutathione s-transferases
GSTs are (usually) detoxification enzymes which protect against elec-
trophiles and products of oxidative stress by conjugation with glutathione 
(Ketterer 1988; Hayes and Pulford 1995; Strange et al. 1998; Hirvonen 
1999). The GST super family consists of at least eight different classes 
of various soluble enzymes (α, µ, π, σ, θ, κ, ω and ζ) with broad and over-
lapping substrate specificity, many of them known to be genetically 
polymorphic (Landi 2000).
In this thesis, the GSTM1 (mu family) and GSTT1 (theta family) 
polymorphisms are considered. They are both gene deletion (null alleles) 
polymorphisms (Hirvonen 1999; Norppa 2003; Parl 2005; McIlwain 
et al. 2006). The genotype with the homozygous deletion of the GST 
gene is called GST null, whereas the genotype having at least one copy of 
the gene is called GST positive. Almost all studies available on GSTM1 
and GSTT1 polymorphisms have been based on genotyping techniques 
differentiating between the homozygous null genotype and the positive 
genotype (including both wild-type homozygotes and heterozygotes). 
More comprehensive GSTM1 and GSTT1 geno type assays, in which 
distinction between the various wild-type and null alleles is made, 
have also been described (Sprenger et al. 2000; Roodi et al. 2004; Parl 
2005). There appears to be ethnic differences in the distribution of the 
GSTM1 and GSTT1 genotype frequencies (Landi 2000). In Caucasians, 
the GSTM1 and GSTT1 genes are lacking from about 50% (Hirvonen 
1999; Garte et al. 2001) and 13–28% of the population, respectively 
(Pemble et al. 1994; Hirvonen 1999; Garte et al. 2001). Among the 
Asian population the frequency of the GSTT1 null genotype is highest 
among the Chinese (64.4%) followed nearby by the Koreans (60.2%) 
(Nelson et al. 1995). The frequency of the GSTM1 null genotype is 
around 50% among Asians, and a little bit lower (30%) among the 
African population (Dandara et al. 2002).
GSTM1 enzyme activity is found in various human tissues (includ-
ing leukocytes and erythrocytes) in GSTM1 positive individuals, who 
have at least one functional allele, but not in GSTM1 null individuals 
homozygous for the gene deletion (Seidegard and Pero 1988; Seidegard 
et al. 1988; Wiencke et al. 1990). GSTM1 has an important role in the 
deactivation of carcinogenic intermediates of polycyclic aromatic hydro-
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carbons (PAHs) (Bolt and Thier 2006). As the GSTM1 null genotype is 
common and expected to increase individual sensitivity to many carcino-
gens, the effect of GSTM1 polymorphisms on the risk of various types of 
human cancer has extensively been studied (Parl 2005; McIlwain et al. 
2006; Dong et al. 2008). Although the results are somewhat conflicting, 
the GSTM1 null genotype has been associated with an increased risk of 
lung, bladder, prostate, and head and neck cancer, and acute leukemia 
(Brockmoller et al. 1994; McWilliams et al. 1995; Rebbeck 1997; Strange 
et al. 1998; Hirvonen 1999; Houlston 1999; Strange and Fryer 1999; 
Benhamou et al. 2002; Engel et al. 2002; Hashibe et al. 2003; Parl 2005; 
Ye and Song 2005; McIlwain et al. 2006; Dong et al. 2008; Hiyama et 
al. 2008; Lacko et al. 2009; Mo et al. 2009). GSTM null genotype has 
been suggested to increase the incidence of lung cancer among nonsmok-
ers exposed to environmental tobacco smoke (Bennett et al. 1999). A 
recent review systematically examined the results of 161 meta-analyses 
and pooled analyses for various genetic polymorphisms and cancer risk 
published through March 2008 (Dong et al. 2008). Assuming a very 
low prior probability (0.000001) and statistical power to detect an odds 
ratio of 1.2, the only associations remaining noteworthy were between 
GSTM1 null and risk of bladder cancer and acute leukemia. For lung 
cancer, seven meta-analyses and pooled analyses have consistently found 
a modest but statistically significant increase in risk for persons with the 
GSTM1 null genotype, with summary odds ratios ranging from 1.17 to 
1.54 (Carlsten et al. 2008). The latest meta-analysis of 98 studies showed 
an odds ratio of 1.22 (95% confidence interval = 1.14, 1.30) when all 
studies were considered, but no association was seen when only the 
largest five studies were included; furthermore, the GSTM1 null status 
conferred a significantly increased risk of lung cancer to East Asians but 
not to Caucasians (Carlsten et al. 2008).
Meta-analyses and pooled analyses were not, however, able to demos-
trate a clear association between GSTM1 genotype, smoking, and lung 
or bladder cancer (Benhamou et al. 2002; Engel et al. 2002; Taioli and 
Raimondi 2005; Vineis et al. 2007; Carlsten et al. 2008) Vineis et al 
(2007) observed a cumulative effect of the combination of the expected 
at risk genotypes for genes involved in metabolism of tobacco-related 
carcinogens (GSTM1, GSTT1 and CYP1A1); the risk of lung cancer 
increased with the combination GSTM1 null, GSTT1 null, and CYP1A1 
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2B or 4 alleles both in smokers and nonsmokers. For bladder cancer risk, 
no multiplicative interaction between the GSTM1 null genotype and 
cigarette smoking could be demonstrated, but an additive interaction was 
seen (Engel et al. 2002). The GSTM1 null genotype has been associated 
with increased risk of esophageal and gastric cancers in smokers (Huang 
2004; La Torre et al. 2005).
Reviews have indicated that the risk of breast cancer for Caucasian 
women with the GSTM1 positive genotype is higher compared with 
subjects lacking the GSTM1 enzyme (Roodi et al. 2004; Parl 2005).
The null genotype of the GSTT1 gene shows no GSTT1 activity 
(Pemble et al. 1994). GSTT1 positive individuals have at least one un-
deleted allele. GSTT1-mediated glutathione conjugation detoxifies, e.g., 
epoxide metabolites of butadiene and monohalomethanes, cytostatic 
drugs, hydrocarbons and halogenated hydrocarbons (Schroder et al. 
1992; Norppa et al. 1995; Wiencke et al. 1995; Bolt and Thier 2006), 
but may also be part of a metabolic activation route for both groups of 
chemicals. The GST class theta is highly expressed in human adult liver 
(Mera et al. 1994; Juronen et al. 1996). Actually, liver and kidney are the 
organs that express the highest levels of GST theta in the human body 
(Landi 2000). GSTT1 is a particularly interesting susceptibility factor 
in studies assessing effect biomarkers examined from blood, since it is 
expressed in erythrocytes and could thus affect the local metabolism of 
its substrates (Schroder et al. 1992; Norppa et al. 1995). Nevertheless, 
no GSTT1 activity in lymphocytes has been detected (Juronen et al. 
1996). The GSTT1 null genotype has been connected with increased 
risk of lung cancer, colorectal cancer, meningioma, head and neck can-
cer, and acute leukemia (Hashibe et al. 2003; Ye et al. 2004; Chen et al. 
2005; Lai et al. 2005; Taioli and Raimondi 2005; Ye and Song 2005; 
Lacko et al. 2009; Liao et al. 2009). Raimondi et al. (2009) observed a 
non-significant positive interaction between the GSTT1 null genotype 
and smoking for colorectal adenoma risk.
n-acetyltransferases
In addition to glutathione conjugation, reactions catalyzed by N-acetyl-
transferases (NATs) are important metabolic pathways of xenobiotics 
in humans (Hirvonen 1999; Hein 2000). Cytosolic NATs metabolize 
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xenobiotics with primary amine and hydrazine structures, including 
carcinogens such as 2-aminofluorene, benzidine, 4-aminobiphenyl, 
4,4-chloroaniline, and 2-naphtylamine either by activation (O-acetyla-
tion) or detoxification (N-acetylation) (Blum et al. 1990; Vatsis et al. 
1995; Hirvonen 1999). In humans, two genes, NAT1 and NAT2, are 
involved in the N-acetylation of xenobiotics (Kadlubar et al. 1992). The 
NAT2 enzyme is the predominant form in the liver, while the NAT1 
enzyme dominates in other tissues. Both enzymes are also polymorphic.
In this thesis, only the NAT2 gene is considered. NAT2 is a polymor-
phic enzyme involved in the metabolism of arylamines. Individuals can 
be classified as either slow or rapid NAT2 acetylators. Several defective 
NAT2 variant alleles have been described (Vatsis et al. 1995; Grant et al. 
1997; Hein 2000). The NAT2 slow acetylator genotype is conferred by 
any combinations of several mutant alleles (Vatsis et al. 1995; Grant et 
al. 1997; Hein 2000). 50–63% of Caucasians have two NAT2 variant 
alleles with reduced enzyme activity (slow acetylators). Rapid acetylators 
are either homo- or heterozygous for the rapid (“wild-type”) allele (see 
(Hirvonen 1999); Japanese and Chinese populations are mostly (92% 
and 80%) rapid acetylators. 
NAT2 rapid acetylators have been noted to have an increased risk 
of colon cancer, whereas slow acetylators have been described to have a 
higher risk of bladder cancer (Marcus et al. 2000; Marcus et al. 2000; 
Hein 2002; Chen et al. 2005; Struewing et al. 2005; Dong et al. 2008). 
Dong et al. (2008) who evaluated 161 pooled and meta-analyses on 
genetic polymorphisms and cancer risk, considered the influence of 
NAT2 slow acetylator status on bladder cancer risk (odds ratio 1.46; 
95% confidence interval, 1.26–1.68) among the four most noteworthy 
associations. There is evidence for a multiplicative interaction between 
smoking and NAT2 slow genotype in determining bladder cancer risk 
(Marcus et al. 2000). The increased risk of colorectal cancer among NAT2 
rapid acetylators has been associated with smoking and red meat intake 
(Chan et al. 2005). In addition, the NAT2 rapid acetylator genotype 
has been reported to increase the risk of lung cancer among Taiwanese 
women exposed to cooking oil fumes (Chiou et al. 2005), bladder cancer 
among benzidine-exposed workers (Carreon et al. 2006), and hepatocel-
lular carcinoma among red meat consumers (Huang et al. 2003). NAT2 
polymorphisms have also been associated to malignant mesothelioma 
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development, even if the results have been contradictory (Gemignani 
et al. 2009). In a recent study, the NAT2 fast acetylator genotype also 
showed an increased risk, although not significant, for malignant me-
sothelioma in asbestos-exposed subjects as well as in the entire studied 
population (Betti et al. 2009).
the influence of GSTM1, GSTT1 and NAT2 
genotypes on cytogenetic biomarkers
Many studies have been conducted to clarify the possible influence of 
the presence or absence of a specific genotype both on the basal and 
induced level of cytogenetic biomarkers. Several of them failed to find 
an association between GSTM1 genotype and the frequencies of CA’s, 
SCEs or MN in nonexposed control persons (Norppa 2004b; Iarmarco-
vai et al. 2008). Nevertheless, the lack of glutathione S-transferase M1 
GSTM1 null genotype has been associated with increased sensitivity 
to genotoxicity of tobacco smoke. GSTM1 null smokers also showed 
an increased frequency of CAs (Scarpato et al. 1997; Norppa 2001; 
Norppa 2004b; Tuimala et al. 2004) and SCEs (van Poppel et al. 1992; 
van Poppel et al. 1993) in their lymphocytes and benzo[a]pyrene diol 
epoxide adducts in lung cell DNA (Alexandrov et al. 2002). GSTM1 null 
bus drivers, all nonsmoking, exposed to polluted city air had a higher 
frequency of lymphocyte CAs than GSTM1 positive drivers, which may 
indicate sensitivity to the genotoxic effects of PAH-containing air pollut-
ants in general (Knudsen et al. 1999). In a group of coke oven workers, 
MNBNC frequency was found to be lower in GSTM1 positive subjects 
compared with the GSTM1 null genotype, even if the difference did not 
reach significance (P = 0.12) (Leng et al. 2004). However, an associa-
tion of GSTM1 null genotype with lower baseline MN frequency was 
detected by Leopardi et al. (2003) (Leopardi et al. 2003; Iarmarcovai 
et al. 2006; Perez-Cadahia et al. 2008), and (for C- MN) (Iarmarcovai 
et al. 2006). Similarly, a possible protective role of GSTM1 null genotype 
was found in arsenic-induced toxicity (skin lesions) through drinking 
water (Ghosh et al. 2006).
The GSTT1 null genotype has been associated with an increased 
level of SCEs in lymphocytes, with no association to smoking or other 
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known exposure (Norppa et al. 1995; Schroder et al. 1995; Wiencke et 
al. 1995; Norppa 2001; Laffon et al. 2002a,b; Norppa 2004b). A couple 
of studies also suggest that the GSTT1 null genotype is associated with 
higher CA level in lymphocytes (Landi et al. 1998; Sram et al. 1998; 
Sram et al. 2004; Tuimala et al. 2004). Induction of CAs and MN by 
diepoxybutane (DEB) was also seen to be higher in whole blood cul-
tures of GSTT1 null than GSTT1 positive subjects (Landi et al. 1998; 
Vlachodimitropoulos et al. 1998). In a study performed on styrene-
exposed workers, GSTT1 null genotype was associated with higher 
frequencies of micronucleated lymphocytes (Migliore et al. 2006). In 
farmers exposed to pesticides, the GSTT1 positive genotype was as-
sociated with increased frequencies of MN and SCE as compared with 
controls (Costa et al. 2006). However, most of the studies failed to show 
a significant effect of GSTT1 genotype on the baseline level of MN 
(Laffon et al. 2002a,b; Leopardi et al. 2003; Godderis et al. 2004; 
Ishikawa et al. 2004; Leng et al. 2004; Silva Mdo et al. 2004; Teixeira 
et al. 2004; Migliore et al. 2006; Perez-Cadahia et al. 2008).
Several studies have indicated increased in vitro sensitivity to various 
genotoxins in blood cultures of GSTM1 null and GSTT1 null subjects. 
A good example is the 1,2:3,4-DEB sensitivity of GSTT1 null individu-
als (Norppa 2001). DEB is an efficient inducer of SCEs (Wiencke et al. 
1991), and this induction is much higher in whole-blood lymphocyte 
cultures of GSTT1 null than positive subjects (Norppa et al. 1995; 
Wiencke et al. 1995; Norppa 2001). Induction of CAs and MN by 
DEB was also seen to be higher in whole blood cultures of GSTT1 null 
than GSTT1 positive subjects (Landi et al. 1998; Vlachodimitropoulos 
et al. 1998).
The possible effect of NAT2 genotype on the basal level of chromo-
some damage has been evaluated in several studies. NAT2 slow acetylation 
genotype seems to elevate the basal level of CAs and SCEs (Norppa 2001; 
Norppa 2004). The reason for this is probably the reduced capacity to 
detoxify some endogenous genotoxins. High baseline level of lymphocyte 
CAs has been associated with the NAT2 slow acetylation genotype with 
no association to exposure (Knudsen et al. 1999; Norppa 2001), regard-
less of smoking (Norppa 2004). A slight increase in chromosome damage 
was also found in NAT2 slow acetylator floriculturists with low levels of 
exposure (Scarpato et al. 1996b). On the other hand, Hernández et al. 
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(Hernandez et al. 2006) obtained results that indicated that rapid (or 
intermediate) acetylators had significantly more MNBNCs (P = 0.032) 
than slow acetylators after radioiodine treatment. The basal levels of MN 
in the same study were not significantly different between NAT2 slow 
and NAT rapid genotypes. 
No association of biomarker response (i.e. formation of CAs, SCEs 
and MN) with regard to GSTM1 and GSTT1 genotypes was observed in a 
study of automobile painters (Testa et al. 2005). Leng et al (2004) neither 
detected any influence of GSTT1 and NAT2 genotypes on MNBNC fre-
quencies among coke-oven workers. In a recent review, GSTM1, GSTT1 
or NAT2 genotypes did not clearly come up as variables affecting MN 
frequency (Dhillon et al. 2011). However, polymorphisms in XRCC1 
(X-ray repair complementing defective repair in Chinese hamster cells 1), 
ERCC2 (excision repair cross-complementing rodent repair deficiency, 
complementation group 2), CYP2E1 (cytochrome P-450 2E1) and MTR 
(methionine synthase) were consistently associated with MN formation.
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The main goal of this study was to examine the applicability of the 
lymphocyte MN assay as a biomarker in occupational genotoxic expo-
sure. In order to optimize the sensitivity of the methods in detecting 
occupational exposure, it was necessary to clarify some methodological 
aspects and factors affecting the baseline level and the mechanistic origin 
of micronuclei.
The detailed aims were:
1. To differentiate MN containing fragments and whole chromo-
somes, in order to estimate if these two classes of MN should 
separately be assessed.
2. To examine the influence of cell culture time and use of Cyt-B on 
the frequency and contents of MN.
3. To evaluate the suitability of uncultured T-lymphocytes in MN 
analysis.
4. To assess the involvement of sex chromosomes in micronucleation 
and chromosome malsegregation.
5. To investigate the formation of MN from chromosomes and frag-
ments lagging behind in anaphase, with a special reference to the 
X chromosome and use of Cyt-B. 
6. To survey the suitability of BrdU labeling in analyzing MN as an 
alternative method to the cytokinesis-block technique.
7. To evaluate the effect of occupational pesticide exposure on lym-
phocyte MN frequency and the possible influence of the genetic 
polymorphisms of glutathione S-transferases M1 (GSTM1) and 
T1 (GSTT1), and N-acetyltransferase 2 (NAT2). 
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study subjects
Five healthy non-smoking male donors (age range 41–50 years) were 
examined in Paper I, and five healthy non-smoking women (47–60 years 
of age) were chosen as the blood donors of Paper II. The third study 
(Paper III) was based on two sets of experiments. For the first one, five 
non-smoking women, aged 47–60 years, were included. The second set 
was performed with four women and 10 men divided in two age groups 
(<30 years and >50 years). In the studies IV and V (Papers IV and V), 
lymphocytes from a 62-year-old woman were examined.
In the last paper the study population consisted of 34 pesticide-
exposed greenhouse workers, 20 men and 14 women, employed in the 
production of flowers in Tuscany, Italy (Paper VI). The control group 
contained 33 healthy unexposed persons, 17 men and 16 women, from 
the same geographical region. At the time of drawing samples for the 
cytogenetic determination, a personal history questionnaire was filled-in. 
The questionnaire covered standard demographic questions as well as 
medical, lifestyle, and occupational questions. For the exposed group, a 
further questionnaire was completed including specific questions related 
to farming: pesticide application, use of protective measures, etc. The 
individuals examined included non-smokers, smokers, and ex-smokers. 
Table 1 in Paper VI shows the main characteristics of both groups.
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Methods
Lymphocyte separation, cell culture, and slide 
preparation
In all studies, lymphocytes were cultured in tissue culture tubes contain-
ing RPMI 1640 medium with L-glutamine (Gibco Life Technologies, 
Paisley, UK) supplemented with 15% fetal calf serum (Gibco, UK), 1% 
phytohaemagglutinin (PHA; Murex Diagnostics, UK), 1% L-glutamine 
(200 mM; Gibco, Grand Island, NY, USA) and 1% penicillin-strepto-
mycin solution (10 000 IU/ml penicillin, 10 000 µg/ml streptomycin; 
Gibco, UK) in 5% CO2 atmosphere. Each experimental point was 
represented by duplicate cultures from each blood donor.
In Paper I, mononuclear cells were isolated from whole blood as 
described earlier (Lindholm et al. 1991; Norppa et al. 1993), and 5-ml 
cultures were established at a mononuclear cell density of 1.5–2.0 x 
105/ml. The cells were cultured for total culture times of 52, 64 and 76 
h. The cell specimens were prepared using a cytocentrifuge (Shandon, 
Cytospin 2, UK). The slides were fixed in absolute ethanol at -20 °C and 
were kept at -20 °C until in situ hybridization (Paper I).
In Paper II and in the first set of experiments in Paper III, purified 
T-lymphocytes were used. T-lymphocytes (CD3-positive cells) were 
immunomagnetically sorted from both cultured and uncultured cell 
suspensions by using the miniMACS (magnetic activated cell sorting) 
system (Miltenyi Biotec) as explained in Papers II and III. The 72-h cul-
tures were established, with and without Cyt-B, as previously described 
(Norppa et al. 1993; Surralles et al. 1995). In the second set of Paper 
III, isolated mononuclear cells cultured for 65 h were used, with and 
without Cyt-B. The cell specimens were prepared using a cytocentrifuge 
(Shandon, Cytospin 2, UK), fixed in absolute methanol at -20 °C, and 
stored at -20 °C until in situ hybridization.
In studies of female anaphase aberrations and MN, isolated mono-
nuclear leukocytes were cultured without Cyt-B (Paper IV) and with 
Cyt-B (Paper V) for 72 h. In order to identify the late-replicating X 
chromosome a pulse treatment with BrdU (10 µg/ml) for the last 7 h of 
culture was used. Anaphase-telophase cells were collected by applying a 
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modification (Lindholm et al. 1991) of the hypotonic technique of Ford 
and Congedi (1987). In brief, a 10% dilution of RPMI 1640 medium 
was used as a hypotonic solution followed by an immediate fixation. 
Slides were prepared after methanol-acetic acid fixation as described by 
Lindholm et al. (1991) and stored in room temperature until in situ 
hybridization.
In studies of the pesticide-exposed workers and their referents (Paper 
VI), whole-blood lymphocyte cultures were set up as described earlier 
(Luomahaara and Norppa 1994), 1994), except that a DNA base ana-
log 5-bromodeoxyuridine (BrdU; Calbiochem, USA) was added to the 
culture medium at the start of the experiment. BrdU closely resembles 
thymine, and is efficiently incorporated into the elongating DNA strands 
during replication (Wilson and Thompson 2007). BrdU can be added to 
the cultures at different times but, to obtain the most efficient labeling 
of MN and chromatin buds, addition between 0 and 24 hr after initia-
tion of the cultures has been considered the best (Serrano-Garcia and 
Montero-Montoya 2001). To obtain comparable data on the potential 
effect of BrdU concentration, two different concentrations (0.5 and 
1 µg/ml) were used. BrdU and PHA were washed away after 42 hours 
of culture and culturing was continued for additional 20 h. The cells 
were harvested and, fixed, and prepared on microscopical slides by the 
air-drying method as described in detail in Paper VI.
Cytochalasin-B
Cytochalasin-B (Cyt-B) (Sigma, St. Louis, MO, USA;), used to induce 
cytokinesis block, was diluted in PBS (phosphate buffered saline) from 
a stock solution of 2 mg/ml (in dimethylsulfoxide) and stored in -70°C. 
When used, it was added at a final concentration of 3 µg/ml (Paper I) or 
6 µg/ml at 24 hours (the 2nd set in Paper III) and at 44 hours (Papers 
II and V, the 1st set in Paper III).
dnA probes
A synthetic oligomer probe, SO-αAllCen, detecting a conserved region 
of the alphoid DNA monomer at the centromeres of every human chro-
mosome (Meyne et al. 1989) labeled with Digoxigenin 3´End Labelling 
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Kit (Boehringer Mannheim, Germany) was used at a concentration of 
2.5 µg/ml in Papers I and II. For the detection of the X chromosome 
in Paper II, a commercial X-chromosome-specific biotin-labeled cen-
tromeric α-satellite probe (DXZ1; Oncor) was used. In Paper III, the 
DXZ1 probe was used together with a Y-chromosome-specific centro-
meric α-satellite probe (DYZ3; Oncor). A biotin labeled X chromosome 
painting probe (1066-XB; Cambio) and a biotinylated pancentromeric 
probe (1141-B; Cambio) were used in Papers IV and V.
Fluorescence in situ hybridization
FISH was performed as described by Norppa et al. (1993) with modi-
fications suggested by Catalán et al. (1995) and Surrallés et al. (1995) 
(Papers I, II, and III) and as explained in Papers IV and V. The labeling 
efficiency of the probes was checked, and the analysis was only performed 
if >90% of the nuclei on the slides showed appropriate labeling.
The slides were stained with 5 µg/ml DAPI (4’,6-Diamidino-2-
phenyl-indole-dihydrochloride hydrate; Aldrich) and 1 µg/ml propidium 
iodide (PI, Aldrich) and mounted in antifade solution (Johnson and 
Nogueira Araujo 1981) (Paper I). Figure 4 shows a summary of the 
FISH procedures.
Isolation of lymphocytes
Hybridization, post-hybridization washes, and antibody detection
Analysis of the stained cells with epifluorecence microscopy
Paper I 
Pan-
centrometric 
probe
Paper II 
Pan-centrometric 
probe and 
X-centrometric 
probe
Paper III 
X- and Y- 
centrometric 
probes
Paper IV 
X-chromosome 
painting probe 
and pan-
centrometric 
probe
Paper V 
X-chromosome 
painting probe 
and pan-
centrometric 
probe
Fixation of cells
Protease pretreatment of cells
Separate denaturation of probes and slides
Figure 4. Illustration of the FISH staining procedure used in papers I–V.
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BrdU detection 
In Papers IV, V, and VI, the BrdU label was detected by immunofluores-
cence. Briefly (see Figure 5), following denaturation, a primary antibody 
(mouse anti-BrdU FITC*; Becton Dickinson) was applied, after which 
a secondary antibody (Paper VI: anti-mouse IgG whole molecule FITC 
conjugate; Sigma; Papers IV and V: FITC-conjugated rabbit anti-mouse 
antibody; Sigma) and (in Papers IV and V) a tertiary antibody (goat 
anti-rabbit FITC-conjugated antibody) were applied.
Figure. 5. Description of the principle of the anti BrdU-staining procedure 
(Paper VI).
Genotype analyses
The genotype analyses were performed as described in detail in Paper 
VI. The genotypes studied were GSTM1, GSTT1, and NAT2. For each 
polymorphism, the subjects were classified in two genotype groups. 
GSTM1 null subjects were homozygous for a gene deletion and were, 
therefore, devoid of GSTM1 activity, while GSTM1 positive subjects 
were heterozygous or homozygous for the presence of the gene and 
consequently expected to express the GSTM1 enzyme. A similar kind of 
deletion polymorphism also affected the GSTT1 gene, with GSTT1 null 
and positive genotypes. For NAT2, the subjects were classified as slow 
Preheating of slides in PBS 70–75 °C for 5 min
DNA denaturation in 40% formamide/2 x SSC, 70–75 °C for 5 min
3 x washes in PBS, RT, 1 min each
Incubation with primary antibody, mouse anti-BrdU FITC, 37 °C, 30 min
3 x washes in PBS, RT, 1 min each
Incubation with secondary antibody, anti-mouse lgG whole molecule FITC conjugate
3 x washes in PBS, RT, 1 min each
Slides air dried, mounted in antifade solution and analysed with epifluorescence
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acetylators, if they had two NAT2 alleles associated with slow acetyla-
tion reaction; all other combinations were classified as fast acetylators.
slide scoring
An outline of subjects studied and number of cells scored in the six 
papers are presented in Table 1. The scoring criteria for identification of 
binucleate cells and the criteria for identification and scoring of MN in 
binucleated cells performed in studies I, II and III, were those recom-
mended in Bonassi et al. (2001). All analyses were performed on coded 
slides.
In the studies of the pesticide-exposed workers and their referents 
(Paper VI), the scoring was performed by one microscopist using coded 
slides with a Leitz Laborlux S microscope (Wetzlar, Germany) equipped 
with epifluorescence, using filter block I3. To restrict the scoring to cells 
that had divided once in vitro, MN were scored only in cells showing 
the fluorescent label. A total of 1000 FITC-stained cells were scored for 
each BrdU concentration and person for the number of MN in total 
67 000 cells.
In Paper I, the scoring was performed on coded slides independently 
by two microscopists. Altogether 6000 cells were examined per subject 
and 1800 micronuclei were characterized, at a 1250x magnification for 
the presence of C+ signals using filter blocks I3 (and FITC). 
At least 100 MN were analyzed for the presence of either any whole 
chromosome or the X chromosome by two scorers working independent-
ly in Paper II. The total number of MN scored was 1532. The frequency 
of MN was analyzed by scoring 3000–7965 cells per experimental point. 
In cultures containing Cyt-B, the analysis was restricted to binucleate 
cells. To accurately compare binucleate with mononucleate cells, the MN 
frequencies obtained in binucleate cells were divided by two (Fenech 
and Morley 1985). The MN frequencies were expressed per 103 nuclei.
In both sets of experiments of Paper III, the number of hybridization 
signals for the X and (in the men) Y chromosomes was analyzed from 
the nuclei of 2000 mononucleate (uncultured T cells and cell cultures 
without Cyt-B) or binucleate (cultures with Cyt-B) cells per donor and 
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cell type. The analyses were done by two trained microscopists working 
independently, each scoring half of the cells in each experiment.
From the different types of FISH signal distributions, the frequency 
of hyperdiploidy (% HRD) and the frequency of reciprocal gain and 
loss (% RGL) were calculated (Paper III). The % HRD reflects, both 
in mononucleate and binucleate cells, the frequency of nuclei with a 
number of FISH spots (X or Y) higher than normal. Non-disjunction 
in binucleated cells was categorized by the number of signals in nucleus 
1 versus nucleus 2 (1/3 or 0/4) in the binucleated cell. The % RGL, 
which was only applied to binucleate cells where both daughter nuclei 
remain together, is the frequency of binucleate cells with X chromo-
some distributions of 3/1 and 4/0 cells in women and X or Y chromo-
some distribution of 2/0 in men. Thus, only those cells where the total 
number of spots was “correct” (i.e., 4 X-spots in women and 2 in men, 
and 2 Y-spots in men) were included in % RGL. Although some other 
distributions, such as 2/1 and 2/0 in women and 1/0 in men, might also 
result from reciprocal gain and loss – if two spots overlap (Eastmond et 
al. 1995) – they were not included in % RGL.
The frequency of apparent hypodiploidy (% HOD) – nuclei that 
showed less than 2 X-chromosomes in women and no X- or Y-chro-
mosomes in men – was also evaluated. It was acknowledged that over-
lapping and fusion of hybridization signals may result in diploid cells 
being classified as hypodiploid (Eastmond and Pinkel 1990; Eastmond 
et al. 1995; Zijno et al. 1996); this phenomenon could be a problem 
especially when only single-color FISH (X chromosomes in women) 
is used. Hypodiploidy analysis was included to allow comparison with 
some earlier studies on X and Y loss in mononucleate interphase cells 
(Guttenbach et al. 1995).
To yield comparable hyper- and hypodiploidy data for cytokinesis-
blocked and untreated cells, the unit of observation was in both cases the 
single nucleus. Without Cyt-B all intact nuclei were considered, whereas 
all nuclei belonging to intact binucleate cells were scored with Cyt-B.
In Papers IV and V, the slides were scored by two microscopists us-
ing a Leitz Laborlux S (Wetzlar, Germany) microscope equipped with 
epifluorescence including filter blocks A, I3, N2 and a triple band pass 
filter (Chroma, Brattleboro, USA) for simultaneous visualization of 
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rhodamine (red), FITC (green), and DAPI (blue) fluorescence. For the 
analysis of anaphases, we used the criteria of (Lindholm et al. 1991). 
Only cells with clearly separated poles, i.e. anaphase B according to Ford 
and Congedi (1987), were scored. The cells analyzed thus represented 
late anaphases and early telophases; for simplicity, they are all called 
anaphases in the present studies. Only cells showing both rhodamine 
and FITC signals were considered for the characterization of anaphase 
aberrations. The anaphases were classified as bipolar, indicating that the 
cell was in its first division after Cyt-B addition, or multipolar (mostly 
tri- and tetrapolar), representing second or further cell divisions.
An anaphase cell was considered aberrant if it contained lagging 
chromatin or bridge(s). The category lagging chromatin both included 
whole chromatids and chromosomes, as well as fragments lagging be-
hind between the poles. A bridge could be either a chromatid stretching 
between the poles or a side-arm bridge, in which the sister chromatids 
were still partially connected. Laggards could represent a) an X chro-
mosome, when the chromosome or the chromatid was totally painted 
red (see Paper V, Fig. 1 D and E), b) an autosome, when it showed a 
centromeric red signal (see Paper V, Fig. 1 A–C), and c) an autosomal 
fragment, when neither the red paint nor the red centromere signal was 
recorded (see Paper V, Fig. 1 A). In addition, both the active and inactive 
X chromosomes could be distinguished in some anaphases by consider-
ing their BrdU-incorporation patterns. The late-replicating inactive X 
chromosome was completely labeled green; whereas the active X was not 
at all or only partially green. Nevertheless, since the lymphocyte cultures 
were not synchronized, distinction between both X homologues was not 
always possible. About 2000 anaphases (1000 per scorer) were analyzed. 
5000 cells were scored per cell type (i.e. binucleate and multinucleate 
cells) for MN frequency, and 200 MN were characterized per probe (X 
chromosome and pancentromeric probe). As the pancentro meric FISH 
was performed separately from X painting, C- MN contained acentric 
fragments originating from both autosomes and the X chromosome. 
Since the X chromosome is not known to be fragmented more often 
than other chromosomes, X fragments were probably rare among the 
C- MN. Thus, they were not expected to invalidate comparison of frag-
ments in anaphases and in MN.
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statistical analyses
Logistic binomial regression model was used in Paper I to evaluate the 
differences in the frequency of MN and differences in C+ MN between 
mononucleate and binucleate cells. The Egret software package was used 
for the statistical analysis.
In Paper II, the one-tailed t-test for paired observations was used for 
the statistical comparison among uncultured cells and the two types of 
cultured cells.
Comparison among the different types of cells in the first set of 
experiments and between the sex chromosomes and age groups of men 
in the second set (Paper III) were performed by multifactorial analysis 
of variance. The sex effect in the second set was evaluated by using two-
tailed t-test (Statview SE + Graphics, version 1.03).
In studies IV and V, all statistical comparisons were performed by the 
χ2 test using the Statview SE + Graphics v. 1.03 program. 
In the last study, for the assessment of pesticide exposure on the 
MN frequencies taking into consideration several confounding factors, 
multiple linear regression on log-transformed MN frequencies was used 
(Paper VI). For the detection of increase or decrease in MN frequen-
cies for each subject class with respect to the reference class, rate ratio 
(RR) was computed by exponentiation of the regression coefficient of 
each variable after adjusting for the other factors (Bonassi, Ceppi et al. 
1994). To study the influence of GSTM1, GSTT1 and NAT2 genotypes 
(separately and jointly) on the MN data as well as possible interaction 
among genotypes, analysis of variance was used. All statistical analyses 
in Paper I were carried out by using the STAT GRAPHICS package 
(Statistical Graphics, 1989; version 4.0).
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Influence of culture time on the frequency 
and contents of micronuclei (Paper I)
In the first paper, the influence of three different culture times (52, 64 
and 76 h) on the frequency of MN containing whole chromosomes and 
acentric fragments was assessed. We also wanted to investigate whether 
the presence of Cyt-B in the cell cultures had any impact on MN fre-
quency and content.
The results showed a general culture time dependent increase in MN 
frequencies. This trend was noted irrespective of the presence of Cyt-B, 
both in mononucleate and binucleate cells. Furthermore, the results of 
the FISH analysis, visualizing centromeres in the MN, indicated that the 
higher MN frequencies were mainly due to C+ MN, i.e. MN with whole 
chromosomes, which were about 1.5-times more frequent at 64 and 
72 h than at 52 h. The presence of Cyt-B influenced the frequency of 
MN with acentric fragments (C- MN). In binucleate cells the frequency 
of C- MN per 1000 nuclei was lower than in mononucleate cells.
In vivo cytogenetic damage in micronuclei 
(Paper II)
In Paper II, MN frequencies in T-lymphocytes were compared before 
and after cell culture in the presence and absence of Cyt-B. The mean 
frequency of MN per 1000 nuclei was consistently (P < 0.01) lower in the 
uncultured cells than in the cells cultured with or without Cyt-B (Table 
1, Paper II). Cell culture increased the frequency of MN, but binucleate 
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cells formed by Cyt-B had less MN per 1000 nuclei than mononucleate 
cells cultured without Cyt-B. The distribution of C+ and C- MN was 
different (P < 0.01) in uncultured cells and cultured cells. In uncultured 
cells, the great majority of the MN was C+ (71.6%), whereas in cultured 
cells C+ MN (55.2% without Cyt-B, 53.3% with Cyt-B) only slightly 
outnumbered C- MN.
As in Paper I, fragment-containing (C-) MN were slightly more 
frequent in mononucleate cells (7.5/1000 nuclei; without Cyt-B) than 
binucleate cells (5.8/1000 nuclei; with Cyt-B), although the difference 
was not statistically significant. On the other hand, the frequency of 
(C+) MN with whole chromosomes was higher with Cyt-B (9.1/1000 
nuclei) than without it (6.6/1000 nuclei) or in uncultured cells (6.5/1000 
nuclei). This appeared to reflect primarily the high frequency of MN 
harboring the X chromosome in cells cultured with Cyt-B (5.2/1000 
nuclei) in comparison with cells cultured without Cyt-B (3.9/1000 
nuclei) or uncultured cells (2.6/1000 nuclei). In general, cell culture 
increased the frequency of MN with X chromosomes. In binucleate cells, 
as many as 42% of all MN were X-positive; this was clearly higher than 
in cells cultured without Cyt-B (24.2%) and in uncultured cells (28.5%). 
The respective percentages for the prevalence of the X chromosome in 
MN harboring whole chromosomes were 79.8% (with Cyt-B), 44.0% 
(without Cyt-B), and 39.6% (uncultured cells); all these figures are 
much higher than the 4.3% expected assuming equal contribution by 
all chromosomes. Thus, the X chromosome was highly over-represented 
in human T-cell MN in vivo and in vitro, and the use of Cyt-B further 
potentiated X chromosome micro nucleation.
In addition to an increase in the frequency of X-positive MN in the 
presence of Cyt-B, the high prevalence of the X chromosome in binu-
cleate cells was explained by a strong decrease in the frequency of MN 
harboring autosomes in these cells (Fig. 1, Paper II). The frequency of 
MN with autosomes (per 1000 nuclei) was significantly lower in binucle-
ate cells in the presence of Cyt-B compared with both uncultured cells 
and cells cultured in the absence of Cyt-B.
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segregation of sex chromosomes in human 
lymphocytes (Paper III)
In Paper III, two sets of experiments were performed. The aim was to 
evaluate the effects of cell culture and cytokinesis block on the segrega-
tion of the sex chromosomes. In the first experiment, the frequency 
of X chromosome aneuploidy in female T lymphocytes cultured in 
the presence and absence of Cyt-B were compared with in vivo MN 
frequencies in uncultured T cells. Results on the distribution of the X 
chromosome signals in cultured and uncultured T cells of the five older 
women included in the first set of experiments are shown in Tables I 
and II in Paper III. Apparent X hypodiploid nuclei were clearly more 
common than X hyperdiploid nuclei. Multifactorial analysis of variance 
on the frequencies of hyperdiploid or “hypodiploid” nuclei showed no 
significant differences attributable to cell culture, individuals, or use of 
Cyt-B. Examples of the different types of abnormal segregation of the 
X chromosomes are shown in Figure 6.
Figure 6. Examples of abnormal X chromosome segregation patterns 
deviating from the expected 2/2 distribution in cultured binucleate 
lymphocytes of five women in the first experiment of study III visualized 
with an X chromosome specific centromeric probe. The dots indicate the 
centromeres of the X chromosome. The frequency (per 1000 binucleate cells) 
of the type of abnormal segregation is indicated below the binucleate cell.
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In the second set of experiments, both X and Y chromosome aneu-
ploidy and segregation were analyzed in binucleate cells in two age groups 
of men (Table III, Paper III) (Figure 7). This approach also allowed us 
to evaluate the number of polyploid binucleate cells. Only 24 appar-
ently polyploid cells were found in a total of 20,000 cells analyzed, 
which indicated a low polyploidy rate. Examples of the different types 
of abnormal distribution of the X and Y chromosomes among the male 
subjects analyzed are illustrated in Figure 7.
Figure 7. Examples of the most common types of abnormal segregation of 
the X chromosome and the Y chromosome in binucleate lymphocytes of two 
age groups of ten men in study III. The frequency (per 1000 binucleate cells) 
of the type of abnormal segregation is indicated below the binucleate cell.
The older group of men showed somewhat higher mean frequencies of 
X hyper diploid nuclei, “hypodiploid” nuclei, and cells with reciprocal 
gain and loss of the X chromosome than the younger group (Table III, 
Paper III). However, no statistically significant age effects were observed 
for any class of X chromosome malsegregation in the men in the analysis 
of variance.
The mean frequency of binucleate cells with reciprocal gain and loss 
of the Y chromosome was 2.2 times higher (P = 0.001) in the older than 
the younger men, but the age difference was not statistically significant 
X chromosome
Y chromosome
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for the mean frequencies of Y hyperdiploid or “hypodiploid” nuclei. In 
multifactorial analysis of variance, there was a statistically significant 
(P < 0.01) difference between the X and Y chromosomes for the frequency 
of hyperdiploid and “hypodiploid” nuclei as well as for reciprocal gain 
and loss, the X chromosome showing higher malsegregation rates.
In the four women studied in the second set, the mean frequency of 
X chromosome reciprocal gain and loss was similar as in the first series, 
and the 3/1 distribution of X chromosomes between the two nuclei of 
the binucleate cell predominated, although a few 4/0 cells were also 
seen. When the X aneuploidy frequencies of the women in the second 
set were divided by two, to take into account their two X chromosomes, 
men actually appeared to show slightly more X hyperdiploid nuclei, 
X hypodiploid nuclei, and cells with reciprocal gain and loss of the X 
chromosome than women. However, the effects were not statistically 
significant (two-tailed t-test).
X chromosome lagging in female 
lymphocyte anaphase (Paper IV)
In order to analyze 200 aberrant anaphases, over 1.5 million cells were 
screened. Of all cells, 2% were mitotic, and the frequency of anaphases 
was only 0.16% of which 7.96% were aberrant. Most of the aberrations 
found were laggards (71%). The rest were bridges, part of which had 
stretched and broken (19%). 25% of the aberrant anaphases contained 
two or more aberrations.
Half of the 200 laggards characterized by FISH were autosomes, 
33.5% acentric fragments, and 17.5% X chromosomes (Table 2, Paper 
IV). The X chromosome represented 26% of all lagging chromosomes, 
i.e., was highly over-represented among anaphase laggards, assuming 
equal contri bution (4.3%) by all chromosomes. BrdU detection indicated 
that both X homologues contributed equally to the X laggards. In five 
aberrant anaphases, both X chromosomes were lagging.
The relative distance of the laggard to the closer pole (distance to the 
closer pole/distance between poles) was significantly higher for the X 
chromosome than lagging autosomes (P < 0.05, Fisher’s least significant 
difference).
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The analysis of the contents of MN showed a clear increase, in com-
parison with anaphase laggards, in the prevalence of autosomal fragments 
(50%) and the X chromo some (31%), while whole autosomes were 
detected in MN at a lower rate (19%); the differences between MN and 
anaphase laggards were statistically significant (P < 0.01, χ2 test).
Lagging chromosomes in  
cytokinesis-blocked anaphases (Paper V)
To be able to characterize 2000 anaphases, we had to go through almost 
400,000 cells. Most of the anaphases were tetrapolar, but bipolar cells in 
their first division after Cyt-B addition were also frequent. Aberrations 
were very common in multipolar anaphases (34.5%) but fewer among 
bipolar anaphases (5.4%).
The aberrant anaphases were classified into those containing a) lag-
gards, b) bridges and c) both laggards and bridges. Most of the aber-
rant anaphases contained laggards. Laggards were found in 95.2% and 
93.5% of aberrant bipolar and multipolar anaphases, respectively. In 
bipolar aberrant anaphases, the frequency of bridges was 0.25%. Over 
one third of the aberrant anaphases contained two or more aberrations, 
mostly laggards. A closer characterization of the laggards showed that 
most of them, both in binucleate and multinucleate cells, were whole 
chromosomes. In bipolar cells, 75% of the laggards were autosomes, 
whereas 15% were acentric autosomal fragments and 10% X chromo-
somes. These figures were similar as those observed in multipolar cells. 
Both in bipolar and multipolar anaphases, the X chromosome lagged 
more often than would be expected by chance, representing 12% (bipolar 
anaphases) and 7% (multipolar anaphases) of all lagging chromosomes 
The X chromosome was not observed to be involved in anaphase bridge 
formation. Activity status of the lagging X chromosome could be judged 
by BrdU label only in 13 cases (all multipolar anaphases), and 3 of the 
X laggards (23%) were considered inactive.
In comparison with lymphocytes cultured without Cyt-B, bipolar 
anaphases cultured with Cyt-B showed a higher frequency of lagging au-
tosomes, but a lower frequency of lagging X chromosomes and fragments.
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The frequency of MN per 1000 nuclei was 11 times higher in multi-
nucleate cells than in binucleate cells. Considering that most multinucle-
ate cells contain four genomes, while binucleate cells contain two, the 
difference in MN frequency between the two cell types remained 5.7-
fold. The percentages of MN containing fragments, autosomes, and X 
chromosomes were, respectively, 34.9%, 22.3%, and 42.9% in binucleate 
cells, and 19.3%, 60.5%, and 20.2% in multinucleate cells. The high 
MN frequency in multi nucleate cells was primarily due to autosomes, 
with a smaller contribution of fragments and X chromosomes. The 
frequency of X chromosome in MN was higher in binucleate cells with 
Cyt-B than in mononucleate cells without Cyt-B, while the frequency 
of MN with acentric fragments was higher in the latter; this time there 
was no difference in the frequency of MN harboring autosomes between 
binucleate and mononucleate cells.
The conversion of anaphase laggards into MN was examined by 
comparing the frequencies of anaphase laggards and MN (Fig. 2 in 
Paper V). Autosome laggards were very poorly micronucleated in bi-
polar divisions, clearly less efficiently than lagging X chromosomes and 
fragments. X laggards generally formed MN efficiently; without Cyt-B, 
49% of them formed MN, and with Cyt-B practically all X laggards 
appeared to end up in MN. Thus, a lagging X chromosome appeared 
to be micronucleated more often in the presence of Cyt-B than in its 
absence. Also lagging acentric fragments formed MN effectively in the 
presence of Cyt-B (65% in bipolar divisions and 58% in multipolar 
divisions with Cyt-B, 48% without Cyt-B).
Influence of genetic polymorphisms of 
GSTM1, GSTT1, and NAT2 on Mn level 
(Paper VI)
The distribution of the GSTM1, GSTT1, and NAT2 genotypes among 
the greenhouse workers and the controls is shown in Table 1 in Paper 
VI. The GSTM1 null genotype (17/33 controls, 20/30 exposed) and the 
NAT2 slow acetylator genotype (17/32 controls, 18/30 exposed) were 
reasonably well represented among the different groups, for a meaningful 
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statistical analysis, but the low prevalence of the GSTT1 null genotype 
(3/33 controls, 6/30 exposed) restricted conclusions concerning this 
polymorphism.
GSTM1 positive genotype was associated with a slightly higher mean 
MN frequency than GSTM1 null genotype, at both doses of BrdU used 
(Table 4, Paper VI). This was especially noted in smokers, although the 
difference was not quite statistically significant in smokers alone (Table 5, 
Paper VI). NAT2 fast acetylator smokers had an elevated mean frequency 
of micronucleated cells in comparison with slow acetylators at 1 µg/ml 
but not at 0.5 µg/ml BrdU.
Influence of occupational pesticide exposure 
on micro nucleus frequency (Paper VI)
In paper VI, the frequency of MN in cultured lymphocyte was analyzed 
by the anti-BrdU assay in greenhouse workers exposed to genotoxic 
components in pesticides. Two concentrations of BrdU were used in the 
anti-BrdU MN assay. A clear correlation of individual MN frequencies 
between both concentrations used was obtained.
The study indicated a statistically significant effect of pesticide 
exposure on the MN frequency. When comparing all subjects (Table 
3, Paper VI), smoking greenhouse workers had a higher frequency of 
micronucleated cells than the controls at both BrdU concentrations. 
When controlling for confounding factors such as age, sex and smoking, 
the subjects classified as extensive sprayers showed a significant increase 
in MNCs (P = 0.004 at 1 µg/ml BrdU, P = 0.052 at 0.5 µg/ml BrdU) 
when GSTM1, GSTT1 and NAT2 genotypes were taken into account 
(Table 4, Paper VI) in the multiple regression analysis.
Subjects older than 43 years had a significantly elevated MN fre-
quency at 0.5 µg/ml BrdU (P = 0.036; Table 4, Paper VI), whereas 
gender had no significant influence on MN levels. At 1 µg/ml BrdU, 
smokers who smoked less than 20 cigarettes per day had a significantly 
lower MN frequency than non-smokers or heavy smokers.
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Fragments and chromosomes in spontaneous 
micronuclei in vitro and an in vivo
Most MN studies are nowadays based on the CB method in which 
cells that have divided only once in vitro are identified by using Cyt-B 
(Fenech and Morley 1985). However, both Cyt-B and culture conditions 
themselves may modify the frequency and contents of MN (Norppa, 
Renzi et al. 1993). This was demonstrated in the studies involved in this 
thesis (Papers I, II, III and V). For example, the use of Cyt-B increased 
the proportion of X chromosome MN in women radically (Paper II).
We showed that the baseline frequency of MN in cultured human 
lymphocytes increases with culture time (52–76 h) both in mononucle-
ate cells without Cyt-B and binucleate cells with Cyt-B. This effect was 
clearly restricted to MN harboring whole chromosomes, as it only con-
cerned C+ MN (containing centromeric alpha satellite DNA), with no 
influence on C- MN (containing fragments). Thus, MN due to errors of 
chromosome segregation became more prevalent at longer culture times. 
The generation of fragment-containing MN in 64-h and 76-h cultures 
did not markedly differ from the level at 52 h (Paper I). The frequency 
of MN harboring fragments was lower in Cyt-B-induced binucleate cells 
than in cells cultured without Cyt-B. If micronucleation of fragments is 
diminished in the presence of Cyt-B, the efficiency of the CB method 
to identify weak clastogenic effects might be reduced. It is not yet clear 
whether this effect has practical significance.
Our findings also highlight the benefits of using centromere detection 
in conjunction with the MN analysis. Centromere identification allows 
the identification of the mechanistic origin of MN. By using probes 
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identifying the centromere or telomere of the chromosomes/ chromatids 
it becomes possible to determine the mechanistic origin of the MN and 
distinguish clastogens from aneugens. This possibility increases the sen-
sitivity of the assay in a major way. In various other studies concerning 
the spontaneous MN level in cultured human lymphocytes, the average 
proportion of whole chromosomes in MN has usually varied between 
30% and 80%, as measured by CREST antibody or pancentromeric 
FISH (Fenech and Morley 1989; Yager et al. 1990; Norppa et al. 1993; 
Scarpato et al. 1996c; Surralles et al. 1996; Migliore et al. 1997; Calvert 
et al. 1998; Carere et al. 1998; Davies et al. 1998; Migliore et al. 1999; 
Migliore et al. 1999; Thierens et al. 1999; Maffei et al. 2000; Thierens 
et al. 2000; Leach and Jackson-Cook 2001; Bakou et al. 2002). In un-
cultured T lymphocytes of women 47–60 years of age, most MN were 
labeled positive with the centromere probe and were thus expected to 
contain whole chromosomes. The proportion of C+ MN was 71.6% 
compared with 53.3–55.2% in cultured cells (with and without Cyt-B) 
(Paper II). Compared with uncultured cells, the frequency of the C- MN 
per 1000 nuclei was 2.3–2.9 times higher in cultured cells. This could 
probably be due to an expression, after in vitro mitoses, of damage ac-
cumulated in vivo in the quiescent lymphocytes.
The X chromosome was, in general, represented in female micro-
nuclei far more often than would be expected – not only in cultured 
cells but also in uncultured cells. This finding supports earlier reports 
of excessive overrepresentation of the X chromosome in MN of female 
lymphocytes; the involvement of the X in MN has been observed to 
increase with age (Guttenbach et al. 1994; Hando et al. 1994; Richard 
et al. 1994; Catalán et al. 1995). Our results showed, for the first time, 
that the X chromosome is also involved in T cell MN in vivo of women 
and that this phenomenon is not an in vitro artifact, although cell cul-
ture further increases the frequency of X chromosome positive MN. The 
findings suggest that X chromosome aneuploidy is a common event in 
the somatic cells of women.
The present study showed that the direct analysis of MN in rest-
ing G0 stage T lymphocytes in peripheral blood, combined with cen-
tromeric FISH, is a technically feasible possibility for the analysis of 
chromosome breakage and numerical chromosome alteration occurring 
in vivo. Considering biomonitoring of human genotoxic continuous 
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exposure, long-lived T lymphocytes could reflect in vivo genotoxic dam-
age acquired during a longer exposure period. In conclusion, the in vivo 
technique may be useful not only for basic studies, but also applicable 
for monitoring studies. In accordance with many previous studies (see 
Fenech and Bonassi 2011), we also found an increase in the frequency of 
(binucleated) micronucleated cells with age – and in females compared 
to males. Furthermore, the age effect was observed as an increase in the 
percentage of C+ MN. Therefore, it appears that the age effect reflects 
an age-related micronucleation of the sex chromosomes (i.e. X and Y) 
(Hando et al. 1994; Zijno et al. 1996; Norppa and Falck 2003). The 
gender effect can probably be explained by the preferential loss of both 
homologues of the X chromosome (paper IV). 
Involvement of sex chromosomes in 
micronucleation and chromosome 
missegregation 
We found no significant differences in the frequency of nuclei hyperdip-
loid or hypodiploid for the X chromosome in women between uncultured 
T-cells and T-cells cultured with or without Cyt-B, which suggests that 
cultured lymphocytes reflect in vivo aneuploidy rates (Paper III). This 
finding agrees with that of Guttenbach et al. (1995), who could not 
find differences between resting and cultured lymphocytes in X and Y 
hypodiploidy. We did not however, observe a higher frequency of MN 
harboring the X chromosome in the cultured lymphocytes in comparison 
with uncultured T lymphocytes. This may indicate that cell culture affects 
X-micronucleation in women even if no significant effects are observed 
in the frequencies of hyper- or hypodiploid nuclei.
The X+ MN or other types of X malsegregation formed in vitro do 
not markedly affect X aneuploidy rates probably because aneuploidy of in 
vivo origin is so frequent. Binucleate cells with an illegitimate number of 
X chromosome signals (more or less than 4), which apparently are mostly 
derived from in vivo (Zijno et al. 1996a), were the most prevalent types 
of aneuploidy. Our data indicate that less than half of all X hyperdiploid 
nuclei and a minority of apparent hypodiploid nuclei seen in female 
lymphocyte cultures are formed by reciprocal gain and loss in the first 
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in vitro division, much of the rest being of in vivo origin. On the other 
hand, Carere et al. (1999) observed that, in binucleate lymphocytes of 
men, reciprocal gain and loss of the X chromosome (an in vitro event) 
is more frequent than balanced hyperdiploids (a probable in vivo event).
In Paper III, binucleate cells with reciprocal gain and loss of the X 
chromo some constituted about 1% of women’s binucleate cells. These 
figures closely follow the frequencies of X+ MN reported earlier from 
the same experiments (Paper II and Catalán et al. 1998). Our results 
agree with those of Zijno et al. (1996a), who concluded that X chromo-
some loss (MN) and reciprocal gain and loss (“nondisjunction”) occur 
at similar rates in binucleate female lymphocytes.
The correct interpretation of hypodiploidy data remains unclear. The 
high frequencies of hypodiploid interphase cells may partly be due to 
overlapping of FISH signals (Eastmond and Pinkel 1990; Eastmond et 
al. 1995), but the clear age-dependent increase in X and Y loss (Gutten-
bach et al. 1995; Mukherjee et al. 1996) also suggests that hypodiploidy 
analysis yields meaningful data. Accordingly, the present results showed 
a higher hypodiploidy rate for the X than the Y chromosome in men, 
which agreed with our data on hyperdiploidy and reciprocal gain and 
loss of these chromosomes.
We could not demonstrate any effects on sex chromosome segregation 
for Cyt-B-induced cytokinesis block (Paper III). Similarly, Zijno et al. 
(1996b) saw no increase of hyperdiploid nuclei in binucleate cells. These 
results contrast with our previous findings on MN in the same cultures, 
where a higher frequency of MN containing the X chromosome was 
seen when binucleate cells were compared with cells cultured without 
Cyt-B (Paper I; Catalán et al. 1998).
As the X chromosome was the only chromosome we labelled in 
women, we could not distinguish hyperdiploidy from polyploidy (East-
mond et al. 1995). However, polyploids in women do not explain our 
results on hyperdiploidy in men and women, since after correction for 
the number of X copies, the rate was higher (although not significantly) 
in men. Undetected polyploidy was not an important source of error 
probably because of the low frequency of polyploid cells (0.12% in men) 
in comparison with sex chromosome hyperdiploidy.
The lack of a significant difference between the sexes in the frequency 
of X chromosome reciprocal gain and loss was an unexpected finding. In 
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our earlier paper on MN of the same donors (Catalán et al. 1998), we 
found a clearly higher frequency of X+ MN in women than in men and, 
therefore, also expected an elevated rate of gains and losses. Metaphase 
studies have likewise indicated a higher total rate of X malsegre gation 
in women than men (Fitzgerald et al. 1975; Fitzgerald and McEwan 
1977), and Zijno et al. (1996) observed a five times higher frequency of 
X malsegre gation (“nondis junction” and MN combined) in women than 
men. Our findings seem to suggest that X chromosome micronucleation 
and reciprocal gain and loss are originated by different mechanisms. It 
would appear that the high X chromosome loss in women is primarily 
due to excessive micronucleation of the X chromosome rather than 
nondisjunction.
Paper III was the first study where the aneuploidy of both sex chro-
mosomes was simultaneously analyzed in binucleate lymphocytes of men. 
The X chromosome showed higher frequencies of hyperdiploidy, recipro-
cal gain and loss, and apparent hypodiploidy than the Y chromosome. 
This is in agreement with our previous observation of a higher frequency 
of X+ MN than Y+ MN in the same men (Catalán et al. 1998). The dif-
ferent rates of reciprocal gain and loss of the X and Y chromosomes may 
be explained by chromosome-specific mechanisms of nondisjunction, as 
has been suggested for germ cells (Abruzzo and Hassold 1995; Abruzzo 
et al. 1996). In fact, our frequencies of reciprocal gain and loss of the 
Y chromosome were similar as the previously reported frequencies of 
Y-positive MN (Catalán et al. 1998), while reciprocal gain and loss was 
clearly more prevalent than MN for the X chromosome of the men. As 
these classes of X malsegregation showed similar rates in women, it could 
be that nondisjunction affects the homologous X chromosomes similarly, 
but micronucleation would preferentially concern the inactive X (which 
only women have). This hypothesis would explain why females have a 
clearly higher frequency of X chromosome loss in metaphase and X+ MN 
but similar rates of X reciprocal gain and loss in comparison with men. 
Although the preferential involvement of the inactive X in aneuploidy 
has been investigated in several studies (Fitzgerald et al. 1975; Abruzzo 
et al. 1985; Tucker et al. 1996; Surrallés et al. 1996b), conclusions have 
been contradictory and further experi ments are thus required.
An effect of age was observed for Y chromosome reciprocal gain 
and loss, in accordance with the prevoius finding on a clear age-related 
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increase in Y+ MN in the same subjects (Catalán et al. 1998). Similar 
(nonsignificant) trends were seen in the frequencies of Y hyper- and 
hypodiploid nuclei.
Carere et al. (1999) observed a positive correlation with age for both 
hyperploidy and reciprocal gain and loss of the X chromosome. Also in 
our study, the older men had more X hyperdiploid nuclei and reciprocal 
gain and loss than the young, although the effect was not statistically 
significant. Previously, Zijno et al. (1996b) described an age-dependent 
increase in X malsegregation, combining X reciprocal gain and loss and 
micronucleation. They could not find an association between age and the 
rate of putative pre-existing monosomic and trisomic cells, in agreement 
with our finding of a lack of an age effect in X chromosome hypodiploidy. 
An age-dependent increase was described for the frequency of X+ MN 
in men (Hando et al. 1997; Catalán et al. 1998; Carere et al. 1999).
In conclusion, Paper III suggests that the baseline frequencies of X 
hyperdiploidy and apparent hypodiploidy in female lymphocytes are 
not markedly affected by cell culturing or by the use of Cyt-B. Malseg-
regation of the X chromosome is common in lymphocytes of both men 
and women and more frequent than Y-chromosome malsegregation. 
The reciprocal gain and loss of the Y chromosome shows an age effect, 
which together with the previously shown age-dependent formation of 
Y-positive MN indicates a chromosome-specific mechanism of malseg-
regation for the Y chromosome. There does not seem to be any clear sex 
difference for X chromosome hyperploidy or reciprocal gain and loss, 
which would suggest that the high loss of the X chromosome in women 
is due to micronucleation.
Characterization of anaphase laggards 
The fact that the number of aneuploid lymphocytes increases with age 
has been known for years, in fact the X chromosome in women appeared 
to be the chromosome mainly responsible for this loss (Jacobs, Court 
Brown et al. 1961; Fitzgerald and McEwan 1977; Richard, Aurias et al. 
1993). As we, along with others (Guttenbach et al. 1994; Hando et al. 
1994; Richard et al. 1994; Catalán et al. 1995) detected an excess of 
X chromosome containing MN in our previous studies (Papers II and 
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III) we wanted to examine the formation of MN from chromosomes 
and fragments lagging behind in anaphase, with a special reference to 
the X chromosome and use of Cyt-B to get further information on the 
mechanisms of X chromosome loss. In order to do this, we had to go 
through more than 1.5 million cells to obtain ~200 classifiable aberrant 
anaphases. The majority (71%) of the aberrations found were laggards, 
the rest were bridges. In 25% of the cases, two or more aberrations were 
seen in one aberrant anaphase. With appropriate DNA probes using 
FISH technology we also classified the laggards into autosomes, acen-
tric autosomal fragments and X chromosome. Half of the laggards were 
autosomes, while acentric autosomal fragments and the X chromosome 
constituted 33.5% and 17.5% of the laggards, respectively. Of all the 
lagging chromosomes, the X accounted for one-fourth, a fact that made 
us realize that the X chromosome, during the anaphase stage, is more 
prone to be lost than the autosomes. When we compared these results 
with the results of the MN analysis, 50% of the MN contained autosomal 
fragments and 31% contained the X chromosome. MN containing au-
tosomes were found at a much lower frequency (19%) compared with 
what we found in anaphases, respectively. The reason for this difference 
could be lagging chromosomes with a functional centromere are more 
easily reincorporated in the reformed daughter nuclei, while the acentric 
fragments are left outside and eventually forms MN. Furthermore, the 
proximal position of the autosome laggards enables correct segregation 
of the chromosomes resulting in a lower micronucleation. When we 
measured the distance between each laggard and the closest anaphase 
pole we noted that the relative distance to the closest pole was signifi-
cantly higher for X chromosome laggards than for autosomal laggards. 
Another explanation for the lower prevalence of autosomes in MN may 
be selection against cells that have lost autosomes, which carry genes 
important for cell survival (Marshall et al. 1996).
By using DNA probes that identify centromeric regions of chro-
mosomes it is possible to use the CBMN assay to determine the rate of 
aneuploidy in nuclei of binucleate cells (and mononucleate cells) and 
determine malsegregation pattern in these cells (Wang et al. 2004).
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Modifying effect of genetic polymorphisms 
in GSTM1, GSTT1 and NAT2 genes on 
the micronucleus frequency in human 
lymphocytes
Data on the association between the frequency of CAs and cancer risk 
assembled by Nordic (Hagmar et al. 1994), Italian (Bonassi et al. 1995; 
Bonassi et al. 2000) and later European collaborative studies (Hagmar 
et al. 1998; Bonassi et al. 2008) have shown an approximately two-fold 
risk of cancer in subjects with a high level of CAs. The risk was not sig-
nificantly associated with exposure to tobacco smoke and occupational 
carcinogens, i.e. was seen in unexposed subjects and non-smokers alike 
(Bonassi et al. 2000). One of the explanations for these findings is that 
individual susceptibility factors affect both the level of CAs and cancer 
risk.
A large number of studies have suggested that genetic polymorphisms 
influence the risk of developing cancer (McIlwain et al. 2006; Dong et 
al. 2008). Combination of several nonbeneficial alleles is expected to 
increase the risk. It is important to remember that many polymorphisms 
are expected to function as effect modifiers: without exposure they have 
no consequences (Knudsen et al. 2001). The interaction of genotypes 
with tobacco smoking in determining cancer risk has been studied to 
some extent. However, few studies are available on genotype and cancer 
risk with respect to occupational and environmental exposures.
As GSTs play an important role in the metabolism of a wide variety 
of environmental carcinogens (Ketterer 1988), and the polymorphisms 
of both GSTM1 and GSTT1 involve a null genotype, these two GSTs 
are among the most studied low-penetrance cancer susceptibility genes 
so far (Rebbeck 1997; Parl 2005; Bolt and Thier 2006; McIlwain et al. 
2006; Dong et al. 2008).
Several studies have been conducted to evaluate whether genetic 
polymorphisms in GSTM1 and other xenobiotic-metabolizing genes 
affect the baseline level of cytogenetic alterations, as reviewed earlier 
(Norppa 2004b; Iarmarcovai et al. 2008). Most of them failed to find a 
clear association between GSTM1 genotype and the frequencies of CAs, 
SCEs, or MN in unexposed control persons. However, the GSTM1 null 
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genotype has been associated with increased sensitivity to genotoxicity 
of tobacco smoke in several studies. GSTM1 null smokers showed an 
increased frequency of CAs (Scarpato et al. 1997; Norppa 2004b; Tui-
mala et al. 2004) and SCEs (van Poppel et al. 1992; van Poppel et al. 
1993) in their lymphocytes and an increased level of benzo[a]pyrene diol 
epoxide adducts in their lung cell DNA (Alexandrov et al. 2002). These 
findings are consistent with the idea that the lack of GSTM1-mediated 
detoxification results in elevated DNA binding of the reactive metabolites 
of carcinogens in tobacco smoke and increased chromosome damage.
In the present study, we found slightly increased MN frequencies in 
GSTM1 positive donors. Our result primarily concerned smokers and 
control subjects, although the genotype effect was not statistically sig-
nificant for these groups separately. In agreement with our finding, also 
Leopardi et al (2003) and Pérez-Cadahía et al. (2008) saw an increased 
baseline MN frequency in GSTM1 positive subjects. Iarmarcovai et al. 
(2006) observed a higher level of C- MN, harbouring chromosomal 
fragments, in lymphocytes of welders and control subjects with the 
GSTM1 positive genotype; this effect was separately seen in smokers and 
control subjects, in accordance with our findings. A genotype difference 
of similar magnitude, although not statistically significant, was likewise 
observed by Pitarque et al. (2002) (in smoking controls); Laffon et al. 
(2002a), Ceu Silva et al. (2004), Teixeira et al. (2004), and (for C+ MN 
in controls) (Migliore et al. 2006). Five other studies did not, however, 
indicate a higher MN level for GSTM1 positive subjects (Cafiero et al. 
1989; Cheng et al. 1996; Ishikawa et al. 2004; Guven et al. 2005; Laffon 
et al. 2006). In one study (Godderis et al. 2004), reporting no statistically 
significant effect of GSTM1 genotype on MN frequency, data on MN 
frequencies with respect to GSTM1 genotype were not shown.
The possible reasons for the higher MN level of the GSTM1 posi-
tive genotype are not known. Leopardi et al. (2003) suggested that the 
GSTM1 null genotype is associated with greater efficiency in the repair 
of DNA damage, as an adaptive response to the enzyme deficiency; 
alternatively, they considered that the higher incidence of DNA dam-
age in GSTM1 proficient individuals could reflect the involvement of 
glutathione conjugation in the metabolic activation of some chemical 
carcinogens. One explanation could be that the combined conjugation 
activities of various GSTs lead to depletion of the glutathione pool in 
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chronic exposure to low levels of genotoxicants (Kirsch-Volders et al. 
2006). The apparent discrepancy between increased CAs in GSTM1 null 
smokers and increased MN in GSTM1 positive donors may be related 
to the complex effect of smoking on MN level. While smoking seems 
to increase CAs in a dose-dependent manner, the frequency of MN ap-
pears to rise only in heavy smokers, low and moderate smokers showing 
a decreased MN level (Bonassi et al. 2003; Kirsch-Volders et al. 2006).
In our study, the numbers of GSTT1 null individuals were unfor-
tunately too low to draw any conclusions of GSTT1 genotype on MN. 
In other studies, higher baseline levels of lymphocyte SCEs (Norppa 
et al. 1995; Schroder et al. 1995; Wiencke et al. 1995; Knudsen et al. 
1999; Laffon et al. 2002a,b; Silva Mdo et al. 2004) and CAs (Landi et 
al. 1998; Sram et al. 2004; Tuimala et al. 2004) have been described in 
GSTT1 null persons. Iarmarcovai et al. (2006) also reported that the 
baseline level of C+ MN, harbouring whole chromosomes, was elveated 
in lymphocytes of GSTT1 null subjects. However, most studies have 
observed no significant effect of GSTT1 genotype on the baseline level 
of MN (Laffon et al. 2002; Leopardi et al. 2003; Godderis et al. 2004; 
Ishikawa et al. 2004; Leng et al. 2004; Silva Mdo et al. 2004; Teixeira et 
al. 2004; Migliore et al. 2006; Migliore et al. 2006; Perez-Cadahia et al. 
2008). Nevertheless, when data from the available studies were pooled, 
comprising 644 persons, GSTT1 null subjects actually showed a lower 
average MN frequency than GSTT1 positive subjects (Kirsch-Volders 
et al. 2006). This effect only concerned occupationally exposed subjects 
and was age-dependent, so that high MN frequency was associated with 
the GSTT1 positive genotype in the youngest individuals (mean age ~20 
years) but with the GSTT1 null genotype in the oldest individuals (mean 
age ~60 years) – with no genotype effect in the middle age group (mean 
age ~40 years) (Kirsch-Volders et al. 2006).
In a study by Murgia et al. (2007), an association of the GSTT1 posi-
tive genotype and cardiovascular disease was found. A significantly higher 
MN frequency was observed in the cardiovascular disease group than in 
the control group. Subjects with higher MN frequency and GSTT1 posi-
tive genotype also showed a higher mortality rate (Murgia et al. 2007). 
The GSTT1 null genotype was, however, found to be associated with an 
increased frequency of MN in styrene-exposed reinforced plastics work-
ers (Migliore et al. 2006) and in rubber workers (Laffon et al. 2006).
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Although the NAT2 slow acetylator genotype has been associated 
with an increased baseline frequency of CAs, the NAT2 genotype had no 
influence on baseline MN frequencies in our study. The NAT2 genotype 
did not either affect MN induction by pesticide exposure. This is in 
agreement with our earlier studies using the CBMN assay (Scarpato et 
al. 1996a). However, we found an increased frequency of MN in NAT2 
rapid acetylators among smokers (exposed workers and controls com-
bined). This finding is supported by Pluth et al. (2000) who observed 
that heavily smoking rapid acetylators had a higher frequency of stable 
CAs than those with the slow acetylator genotype.
Even though there are suggestions that lymphocytes from subjects 
with unfavorable metabolizing alleles are more susceptible than those 
with favorable alleles to radiation-induced chromosome damage in vitro 
(Au et al. 1999), there are no conclusive findings on whether metabolic 
polymorphisms could affect the level of chromosomal damage induced 
by pesticides in vivo (Bolognesi 2003). Apart from Paper I and the earlier 
study on the same population (Scarpato et al. 1996b), only one study has 
examined the possible effect of genotype (GSTM1 and GSTT1) on MN 
in pesticide-exposed workers – with negative results. CYP1A1, GSTM1, 
GSTT1, and PON were not observed to affect the frequency of Cas in 
pesticide-exposed workers (Scarpato et al. 1996; Au et al. 1999; Gregio 
D’Arce and Colus 2000).
Individual exposure level may vary a lot, therefore a reliable estimate 
of the exposure is important for a correct interpretation of genotype-
exposure interaction (Norppa 2004).
Mn assay and occupational exposure to 
pesticides
Cytogenetic biomarkers have for long been used in monitoring human 
occupational genotoxic exposure to potential carcinogens. A number of 
biomarker studies have been performed to assess altered levels of MN 
in exposed persons. Several of the previous studies have indicated an in-
crease of MN in peripheral lymphocytes of humans exposed to complex 
mixtures of pesticides (see reviews by Bolognesi, 2003, 2011) (Bolognesi 
2003, 2011). Pesticide sprayers together with persons preparing pesticide 
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mixtures, represent the most exposed group of all agricultural workers, 
positive findings being found in 18 out of 27 cytogenetic biomarker 
(CAs, SCEs and MN) studies (Bolognesi 2003, 2011). Consequently, 
occupational exposure to pesticide mixtures was considered to be associ-
ated with a genetic risk including genetic damage at the chromosomal 
level (chromosomal number and -structure) in sprayers (reviewed in 
Bolognesi, 2003, 2011).
Some of the greenhouse workers examined in paper VI, had previ-
ously been analyzed for MN using the CB method (Scarpato et al. 1996a; 
Scarpato et al. 1996b; Scarpato and co-workers 1997), with negative 
results. However, in agreement with the majority of the earlier studies, 
we detected, by using the anti-BrdU MN assay, a statistically significant 
effect of pesticide exposure as well as of age on the frequency of MN. 
The multiple linear regression model showed an especially clear effect 
of the pesticide-exposure in sprayers after adjustment for age, gender, 
smoking, and the metabolic genotypes assessed. In general, occupational 
exposure of floriculturists is characterized by intense pesticide spraying 
seasons alternating with periods of reduced or no exposure (Scarpato 
et al. 1996a or b). The blood samples we processed were drawn during 
extensive pesticide application, while those of Scarpato and co-workers 
(Scarpato et al. 1996a; Scarpato et al. 1996b) were drawn both after 
pesticide spraying and during low exposure season. Thus, the discrepancy 
between the results of the earlier CBMN study and the present anti-BrdU 
assay probably reflected differences in exposure. Our results suggested 
that the workers had been exposed to the genotoxic components of the 
pesticides. Among the pesticides used by the workers, Acephate, Captan, 
Dichlorvos, Dimethoate and Metiram have been reported to be genotoxic 
(see refs in Paper VI).
In this project, the anti-BrdU MN assay was used for the first time in 
biomonitoring of human genotoxic exposure. In the MN assay of human 
exposure to genotoxins, using cultured human lymphocytes, the exclusive 
scoring of cells that have divided once in culture is of high importance 
for the accuracy of the analysis. The anti-BrdU method was chosen as 
an alternative to the well established cytokinesis-block method which 
is most often used to recognize MN in cells that have divided once in 
vitro. One reason for the choice were our previous findings suggesting 
that Cyt-B may interfere with MN formation (Lindholm, et al. 1991 
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and paper I; see discussion on paper I). It has to be recognized that also 
BrdU, as a thymine analogue incorporating into DNA, has genotoxic 
potential and may interfere with MN levels. In our study, we used very 
low and nonclastogenic concentrations of BrdU (0.5 and 1 µg/ml). 
BrdU started to have a dose-dependent effect on MN frequency only at 
20 µg/ml (Roth et al. 1993). As a matter of fact, Montero et al. (1997) 
claimed that the concentration of BrdU in this assay can be set at a low 
concentration, since the affinity of the antibody is very high.
The inclusion of cells that have mostly divided once in the culture 
was achieved by using pulse-labeling with BrdU for 42 hrs, followed 
by washing BrdU and PHA away and further culturing for 20 h. The 
simultaneous use of BrdU and Cyt-B has shown that most BrdU-labeled 
nuclei (81–93%) are in binucleate cells (Autio et al. 1991). The agreement 
of the two methods was likely to be even higher, as some cells probably 
escaped the cytokinesis block at the concentration of Cyt-B used (3 µg/
ml). The BrdU method is convenient to perform on whole blood samples 
as well as on isolated mononuclear cells. The labeled cells and the MN 
are very easily identified, especially if fluorescent dyes are used. As only 
labeled nuclei are scored, the analysis is fast and unambiguous, which 
enables analysis of a great number of cells, if desired. The contents of MN 
were not assessed in paper VI, but it should be possible to combine the 
BrdU method with DNA probes recognizing centromeres and telomeres.
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The present thesis investigated various methodological aspects and bio-
logical factors that are relevant when MN in lymphocytes are used as a 
biomarker of genotoxic effects in occupational exposure. In particular, 
the studies provided new information on the mechanistic origin of 
MN, which is essential for the proper use of this cytogenetic endpoint 
in biomarker studies.
The main conclusions of the thesis are:
1. MN contain either chromosomal fragments or whole chromo-
somes, and both classes of MN represent a considerable share of 
all MN. The proportion of MN harboring whole chromosomes 
increases with age and is higher in women than men. Since the 
genotoxic exposure usually induces only one type of MN, it is 
important to distinguish MN deriving from chromosomal frag-
ments from MN containing whole chromosomes. Fluorescent in 
situ hybridization with DNA probes that identify the centromeric 
α-satellite DNA of chromosomes is the method of choice for 
detecting both clastogenic and aneugenic effects in the MN assay 
(Papers I, II and III).
2. The baseline frequency of MN in cultured human lymphocytes is 
increased with culture time, in both mononucleate and binucleate 
cells. Especially MN harboring whole chromosomes become more 
frequent at longer culture times. The frequency of MN containing 
fragments is lower in Cyt-B-induced binucleate cells than without 
Cyt-B. This phenomenon may reduce the efficiency of the cyto-
kinesis block method to identify weak clastogenic effects, unless 
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centromeres in MN are identified. The use of the cytokinesis block 
method is also associated with a reduced frequency of MN with 
autosomes (Papers I and II).
3. Analysis of MN in uncultured human T-lymphocytes provides a 
new possibility to assess structural and numerical chromosome 
damage in vivo. In women, the in vivo MN mainly contain whole 
chromosomes. Cell culture enhances the proportion of MN har-
boring chromosomal fragments (Paper II).
4. The X chromosome is represented in female lymphocyte MN far 
more often than expected by chance, not only in cultured cells but 
also in uncultured cells. Thus, the preferential micronucleation of 
the X chromosome also occurs in human lymphocytes in vivo and 
is not an in vitro artifact. Cell culture and use of Cyt-B increase 
the frequency of X-chromosome-positive MN but not the frequen-
cies of X hyperdiploidy and hypodiploidy in female lymphocytes. 
Malsegregation of the X chromosome is common in lymphocytes 
of both men and women and more frequent than Y chromosome 
malsegregation. An age effect is detected for the reciprocal gain 
and loss of the Y-chromosome but not of the X chromosome. 
This suggests that the high loss of the X chromosome in women, 
documented in metaphase studies, is due to micronucleation rather 
than non-disjunction (Papers III, IV and V).
5. The high micronucleation of the X chromosome appears to be 
due to its frequent lagging behind during anaphase. Lagging X 
chromosomes and acentric chromosomal fragments form MN 
efficiently, which agrees with the idea that they lack a functional 
centromere and are not attached to the spindle. The lagging X 
chromosomes are distally located in the anaphases, further favor-
ing micronucleus formation. All lagging X chromosomes appear 
to be micronucleated in the presence of Cyt-B, which may explain 
the high prevalence of the X chromosome in MN of binucleate 
cells. The lowered micronucleation of fragments in binucleate cells 
may be due to their reduced anaphase lagging in the presence of 
Cyt-B. Lagging autosomes seldom appear to form MN, suggesting 
that they are still attached to spindle and just delayed in anaphase 
movement (Papers IV and V).
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6. Greenhouse workers showed an increased frequency of lymphocyte 
MN, indicating that the occupational exposure to pesticides in-
volves genotoxic components. Higher micronucleus frequencies 
were associated with the GSTM1 positive genotype in all subjects 
and with the NAT2 fast genotype in smokers, which is opposite 
to what earlier studies have shown for chromosomal aberrations. 
Genetic polymorphisms might explain some of the discrepancies 
observed between the analysis of MN and chromosomal aberra-
tions, e.g., in response to smoking (Paper VI).
7. The results of the greenhouse worker study suggest that the bro-
modeoxyuridine labeling technique could possibly be used as an 
alternative for the cytokinesis block assay in biomonitoring hu-
man genotoxic exposure and effects. Also the effect of age on MN 
formation, an important biological factor affecting the baseline 
level of MN, described in earlier studies using other micronucleus 
techniques, was confirmed with the bromodeoxyuridine assay 
(Paper VI).
The main practical recommendation deriving from the results of this 
thesis is that centromeric fluorescence in situ hybridization should 
routinely be applied when lympho cyte MN are used as a biomarker of 
human genotoxic effects. In exposure to clastogens, this approach offers 
the possibility to remove the potential sensitivity problem associated 
with the high background of MN with whole chromosomes. A specific 
analysis of centro mere-negative MN will also abolish most of the effects 
of age and sex on MN frequency, since these factors are exclusively due to 
the preferential micronucleation of whole sex chromosomes. The use of 
centromere labeling would appear to be particularly important when the 
cytokinesis block method is used in women, as a considerable portion, 
even the majority, of MN in binucleate cells of females can contain the 
X chromosome. Also in exposure to aneugens, centromere identifica-
tion is expected to increase the sensitivity of the MN assay, although it 
remains unclear if an in vivo exposure of humans to aneugens can really 
increase MN in resting peripheral lymphocytes. 
Aneugen exposure may better express itself in MN formed in cells 
that have divided in vivo. Therefore, the second recommendation for 
future studies is that techniques for the analysis of MN formed in vivo 
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should further be evaluated. One alternative is the immunomagnetic 
separation of lymphocytes applied in this thesis. To choose the cell 
population that had the best possibilities to divide during the exposure, 
the leukocyte type to be studied could be selected taking into account 
the half-life of the cells. 
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